"path_id"	"full_path_length.x"	"testable_path_length.x"	"drug_targeted_genes"	"proportion_drug_targeted"	"full_path_length.y"	"testable_path_length.y"	"aberrational_genes"	"proportion_aberrational"	"proportion_of_cohort_w_aberrational_gene_in_path"	"Num_patient_with_aberrational_gene_.s._in_path"	"count_of_aberrational_genes_in_path_cross_cohort"	"max_in_one_gene"	"min_in_one_gene"	"hyperg_p_value"	"hyperg_p_w_FDR"
"354"	"Sema4D induced cell migration and growth-cone collapse"	24	24	5	0.208333333333333	24	24	13	0.541666666666667	0.210526315789474	12	19	4	0	0.000149444861863302	0.0535769714262484
"804"	"G alpha (12/13) signalling events"	75	75	3	0.04	75	75	30	0.4	0.473684210526316	27	50	15	0	0.000176988283648094	0.0601567782088266
"228"	"DAP12 signaling"	164	164	46	0.280487804878049	164	164	56	0.341463414634146	0.754385964912281	43	92	15	0	0.000178830017113385	0.0601567782088266
"320"	"Sema4D in semaphorin signaling"	27	27	6	0.222222222222222	27	27	14	0.518518518518518	0.210526315789474	12	20	4	0	0.000183529322952514	0.0601567782088266
"215"	"Downstream signal transduction"	161	161	46	0.285714285714286	161	161	55	0.341614906832298	0.789473684210526	45	94	15	0	0.000198530570434619	0.0632662423186586
"833"	"Adherens junctions interactions"	30	30	1	0.0333333333333333	30	30	15	0.5	0.315789473684211	18	22	3	0	0.00021213429676592	0.0657743121947013
"239"	"Signaling by FGFR in disease"	177	177	49	0.27683615819209	177	177	59	0.333333333333333	0.771929824561403	44	98	15	0	0.000265876264362808	0.0793427595951079
"276"	"Signaling by EGFR in Cancer"	181	181	47	0.259668508287293	181	181	60	0.331491712707182	0.771929824561403	44	96	15	0	0.000283559373031261	0.0793427595951079
"277"	"Signaling by EGFRvIII in Cancer"	181	181	47	0.259668508287293	181	181	60	0.331491712707182	0.771929824561403	44	96	15	0	0.000283559373031261	0.0793427595951079
"278"	"Signaling by Ligand-Responsive EGFR Variants in Cancer"	181	181	47	0.259668508287293	181	181	60	0.331491712707182	0.771929824561403	44	96	15	0	0.000283559373031261	0.0793427595951079
"302"	"PLCG1 events in ERBB2 signaling"	34	34	8	0.235294117647059	34	34	16	0.470588235294118	0.333333333333333	19	23	3	0	0.000372092292771464	0.0956422178493967
"280"	"Signaling by EGFR"	179	179	46	0.256983240223464	179	179	59	0.329608938547486	0.771929824561403	44	95	15	0	0.000372789177183863	0.0956422178493967
"281"	"Signaling by Overexpressed Wild-Type EGFR in Cancer"	179	179	46	0.256983240223464	179	179	59	0.329608938547486	0.771929824561403	44	95	15	0	0.000372789177183863	0.0956422178493967
"597"	"Transmission across Chemical Synapses"	201	201	22	0.109452736318408	201	201	65	0.323383084577114	0.596491228070175	34	83	3	0	0.000375158682011545	0.0956422178493967
"509"	"PLC beta mediated events"	43	43	6	0.13953488372093	43	43	19	0.441860465116279	0.368421052631579	21	28	3	0	0.000395909162129615	0.0966373128302885
"212"	"NGF signalling via TRKA from the plasma membrane"	206	206	59	0.286407766990291	206	206	66	0.320388349514563	0.789473684210526	45	105	15	0	0.00045872673411429	0.109637712173196
"55"	"Post NMDA receptor activation events"	35	35	16	0.457142857142857	35	35	16	0.457142857142857	0.263157894736842	15	20	3	0	0.000573894748345682	0.126342531983961
"518"	"G-protein mediated events"	44	44	6	0.136363636363636	44	44	19	0.431818181818182	0.368421052631579	21	28	3	0	0.000574721289767655	0.126342531983961
"202"	"Downstream signaling of activated FGFR"	149	149	44	0.295302013422819	149	149	50	0.335570469798658	0.736842105263158	42	86	15	0	0.000578587848599321	0.126342531983961
"214"	"CREB phosphorylation through the activation of Adenylate Cyclase"	7	7	2	0.285714285714286	7	7	5	0.714285714285714	0.12280701754386	7	7	3	0	0.000711670803790754	0.145793537282646
"316"	"Semaphorin interactions"	67	67	15	0.223880597014925	67	67	26	0.388059701492537	0.350877192982456	20	33	4	0	0.000731237098577364	0.147173802857383
"528"	"Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell"	140	140	18	0.128571428571429	140	140	47	0.335714285714286	0.543859649122807	31	60	3	0	0.000794635389499421	0.157176299564152
"209"	"Signaling by FGFR"	162	162	47	0.290123456790123	162	162	53	0.327160493827161	0.736842105263158	42	89	15	0	0.000831975867004231	0.158981027602435
"647"	"Netrin-1 signaling"	42	42	4	0.0952380952380952	42	42	18	0.428571428571429	0.333333333333333	19	25	3	0	0.000843749770939928	0.158981027602435
"340"	"EGFR interacts with phospholipase C-gamma"	33	33	7	0.212121212121212	33	33	15	0.454545454545455	0.315789473684211	18	22	3	0	0.000851217207521571	0.158981027602435
"334"	"DCC mediated attractive signaling"	14	14	3	0.214285714285714	14	14	8	0.571428571428571	0.175438596491228	10	10	2	0	0.00092037928287958	0.167599776723149
"279"	"DAP12 interactions"	179	179	46	0.256983240223464	179	179	57	0.318435754189944	0.754385964912281	43	93	15	0	0.00119062241834211	0.212433110739967
"333"	"Ca-dependent events"	28	28	6	0.214285714285714	28	28	13	0.464285714285714	0.298245614035088	17	20	3	0	0.00122214565851908	0.212433110739967
"304"	"Unblocking of NMDA receptor, glutamate binding and activation"	17	17	4	0.235294117647059	17	17	9	0.529411764705882	0.157894736842105	9	10	2	0	0.00125916884801025	0.212433110739967
"566"	"PKA activation in glucagon signalling"	17	17	2	0.117647058823529	17	17	9	0.529411764705882	0.175438596491228	10	11	3	0	0.00125916884801025	0.212433110739967
"203"	"Signaling by ERBB2"	163	163	48	0.294478527607362	163	163	52	0.319018404907975	0.736842105263158	42	88	15	0	0.0017413976442171	0.284566933206791
"271"	"GRB2:SOS provides linkage to MAPK signaling for Integrins"	15	15	4	0.266666666666667	15	15	8	0.533333333333333	0.157894736842105	9	9	2	0	0.00184484249126204	0.289923609929562
"382"	"p130Cas linkage to MAPK signaling for integrins"	15	15	3	0.2	15	15	8	0.533333333333333	0.157894736842105	9	9	2	0	0.00184484249126204	0.289923609929562
"642"	"Ca2+ pathway"	61	61	6	0.0983606557377049	61	61	23	0.377049180327869	0.385964912280702	22	31	3	0	0.00208465946395653	0.318875394578875
"823"	"Cell junction organization"	85	85	3	0.0352941176470588	85	85	30	0.352941176470588	0.491228070175439	28	51	5	0	0.00216389958000296	0.326640973369088
"596"	"Hemostasis"	497	497	55	0.110663983903421	497	497	137	0.275653923541247	0.947368421052632	54	206	22	0	0.00219909397980711	0.327642488046474
"544"	"Sema4D mediated inhibition of cell attachment and migration"	8	8	1	0.125	8	8	5	0.625	0.0526315789473684	3	5	1	0	0.00230403153684655	0.330404218052588
"107"	"CD28 dependent PI3K/Akt signaling"	21	21	8	0.380952380952381	21	21	10	0.476190476190476	0.368421052631579	21	26	15	0	0.00255513129913454	0.344858906623639
"199"	"Integrin alphaIIb beta3 signaling"	27	27	8	0.296296296296296	27	27	12	0.444444444444444	0.245614035087719	14	15	3	0	0.00280288815002649	0.365310435994951
"149"	"Signaling by SCF-KIT"	144	144	49	0.340277777777778	144	144	46	0.319444444444444	0.736842105263158	42	82	15	0	0.00283403320902986	0.365310435994951
"857"	"Integrin cell surface interactions"	66	66	2	0.0303030303030303	66	66	24	0.363636363636364	0.333333333333333	19	27	2	0	0.00312919130380573	0.398874943752222
"183"	"EPH-Ephrin signaling"	94	94	29	0.308510638297872	94	94	32	0.340425531914894	0.43859649122807	25	43	4	0	0.00323416252567854	0.407725241894749
"64"	"Sema3A PAK dependent Axon repulsion"	16	16	7	0.4375	16	16	8	0.5	0.140350877192982	8	8	1	0	0.00338338912548575	0.417365119887731
"539"	"PKA activation"	16	16	2	0.125	16	16	8	0.5	0.157894736842105	9	10	3	0	0.00338338912548575	0.417365119887731
"856"	"Stimuli-sensing channels"	98	98	3	0.0306122448979592	98	98	33	0.336734693877551	0.421052631578947	24	47	5	0	0.00351595770234125	0.429104371507292
"760"	"Transmembrane transport of small molecules"	618	618	32	0.0517799352750809	618	618	165	0.266990291262136	0.929824561403509	53	205	5	0	0.00375160772856575	0.453044609456797
"23"	"EPHA-mediated growth cone collapse"	34	34	18	0.529411764705882	34	34	14	0.411764705882353	0.280701754385965	16	23	4	0	0.00393125092263635	0.469793152527743
"384"	"DAG and IP3 signaling"	31	31	6	0.193548387096774	31	31	13	0.419354838709677	0.280701754385965	16	19	3	0	0.00407957528790126	0.482492279939906
"807"	"TRP channels"	25	25	1	0.04	25	25	11	0.44	0.192982456140351	11	15	2	0	0.00418596464674104	0.48496327650539
"896"	"Potassium Channels"	99	99	2	0.0202020202020202	99	99	33	0.333333333333333	0.43859649122807	25	41	3	0	0.00422728669244399	0.48496327650539
"814"	"Assembly of collagen fibrils and other multimeric structures"	54	54	2	0.037037037037037	54	54	20	0.37037037037037	0.350877192982456	20	37	5	0	0.00454722746295544	0.511438783196436
"869"	"Elastic fibre formation"	41	41	1	0.024390243902439	41	41	16	0.390243902439024	0.280701754385965	16	22	3	0	0.00480776140617567	0.535491809953974
"337"	"SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion"	14	14	3	0.214285714285714	14	14	7	0.5	0.105263157894737	6	7	1	0	0.00505765087997079	0.557908089983761
"744"	"Integration of energy metabolism"	104	104	6	0.0576923076923077	104	104	34	0.326923076923077	0.491228070175439	28	46	3	0	0.00540022902137238	0.590024479084869
"165"	"Regulation of gene expression by Hypoxia-inducible Factor"	9	9	3	0.333333333333333	9	9	5	0.555555555555556	0.228070175438596	13	13	8	0	0.00560113527691675	0.600536536353095
"303"	"Ras activation uopn Ca2+ infux through NMDA receptor"	17	17	4	0.235294117647059	17	17	8	0.470588235294118	0.12280701754386	7	8	1	0	0.0057731369376457	0.602096807692777
"567"	"PKA-mediated phosphorylation of CREB"	17	17	2	0.117647058823529	17	17	8	0.470588235294118	0.157894736842105	9	10	3	0	0.0057731369376457	0.602096807692777
"817"	"ECM proteoglycans"	55	55	2	0.0363636363636364	55	55	20	0.363636363636364	0.280701754385965	16	26	3	0	0.00583352170976736	0.602913475068102
"796"	"NRAGE signals death through JNK"	45	45	2	0.0444444444444444	45	45	17	0.377777777777778	0.228070175438596	13	21	2	0	0.00591452643772539	0.603870545995247
"556"	"p75 NTR receptor-mediated signalling"	83	83	10	0.120481927710843	83	83	28	0.337349397590361	0.298245614035088	17	34	2	0	0.00600708650232473	0.603870545995247
"385"	"CaM pathway"	26	26	5	0.192307692307692	26	26	11	0.423076923076923	0.228070175438596	13	15	3	0	0.00621124562440789	0.603870545995247
"386"	"Calmodulin induced events"	26	26	5	0.192307692307692	26	26	11	0.423076923076923	0.228070175438596	13	15	3	0	0.00621124562440789	0.603870545995247
"109"	"Signaling by Interleukins"	109	109	41	0.376146788990826	109	109	35	0.321100917431193	0.543859649122807	31	57	15	0	0.00676204495571753	0.646463424451264
"245"	"Signaling by ERBB4"	154	154	42	0.272727272727273	154	154	47	0.305194805194805	0.701754385964912	40	78	15	0	0.00698003328113472	0.661788587942657
"246"	"Synthesis of PIPs at the plasma membrane"	33	33	9	0.272727272727273	33	33	13	0.393939393939394	0.456140350877193	26	34	15	0	0.00800608874475039	0.728948766560539
"341"	"PLC-gamma1 signalling"	33	33	7	0.212121212121212	33	33	13	0.393939393939394	0.280701754385965	16	19	3	0	0.00800608874475039	0.728948766560539
"406"	"Platelet activation, signaling and aggregation"	221	221	39	0.176470588235294	221	221	64	0.289592760180996	0.824561403508772	47	118	22	0	0.00840789925723051	0.753613638460621
"440"	"Cytokine Signaling in Immune system"	308	308	51	0.165584415584416	308	308	86	0.279220779220779	0.754385964912281	43	116	15	0	0.00848788101705433	0.754843158968422
"859"	"Ion channel transport"	167	167	5	0.029940119760479	167	167	50	0.29940119760479	0.543859649122807	31	66	5	0	0.00855918991861793	0.755329525525806
"269"	"CREB phosphorylation through the activation of CaMKII"	15	15	4	0.266666666666667	15	15	7	0.466666666666667	0.105263157894737	6	7	1	0	0.00872943189563791	0.758680987203249
"270"	"Constitutive Signaling by EGFRvIII"	15	15	4	0.266666666666667	15	15	7	0.466666666666667	0.333333333333333	19	23	15	0	0.00872943189563791	0.758680987203249
"58"	"CREB phosphorylation through the activation of Ras"	27	27	12	0.444444444444444	27	27	11	0.407407407407407	0.175438596491228	10	13	3	0	0.0089379316039131	0.770961226267656
"431"	"REV-ERBA represses gene expression"	24	24	4	0.166666666666667	24	24	10	0.416666666666667	0.280701754385965	16	21	8	0	0.00926330472033454	0.788494909030979
"590"	"Norepinephrine Neurotransmitter Release Cycle"	18	18	2	0.111111111111111	18	18	8	0.444444444444444	0.140350877192982	8	10	3	0	0.00927866534768174	0.788494909030979
"47"	"Signal transduction by L1"	21	21	10	0.476190476190476	21	21	9	0.428571428571429	0.192982456140351	11	12	3	0	0.0094099671588882	0.793773050644625
"211"	"GAB1 signalosome"	104	104	30	0.288461538461538	104	104	33	0.317307692307692	0.631578947368421	36	61	15	0	0.00986945997995448	0.826456450975472
"43"	"Interleukin-2 signaling"	47	47	23	0.48936170212766	47	47	17	0.361702127659574	0.43859649122807	25	35	15	0	0.00994981606591483	0.827147795719745
"296"	"Platelet Aggregation (Plug Formation)"	37	37	9	0.243243243243243	37	37	14	0.378378378378378	0.263157894736842	15	18	3	0	0.0100253261539918	0.827429233968524
"90"	"PKA-mediated phosphorylation of key metabolic factors"	5	5	2	0.4	5	5	3	0.6	0.0526315789473684	3	3	1	0	0.0103232979384587	0.839936587939244
"170"	"betaKlotho-mediated ligand binding"	3	3	1	0.333333333333333	3	3	2	0.666666666666667	0.0350877192982456	2	2	1	0	0.0112370530989825	0.85748121768373
"193"	"Netrin mediated repulsion signals"	10	10	3	0.3	10	10	5	0.5	0.12280701754386	7	7	3	0	0.0113611175454686	0.85748121768373
"634"	"IRAK2 mediated activation of TAK1 complex"	10	10	1	0.1	10	10	5	0.5	0.105263157894737	6	6	2	0	0.0113611175454686	0.85748121768373
"635"	"IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation"	10	10	1	0.1	10	10	5	0.5	0.105263157894737	6	6	2	0	0.0113611175454686	0.85748121768373
"127"	"EPHB-mediated forward signaling"	41	41	15	0.365853658536585	41	41	15	0.365853658536585	0.263157894736842	15	18	2	0	0.01204019894842	0.902795494586308
"98"	"Interleukin receptor SHC signaling"	28	28	11	0.392857142857143	28	28	11	0.392857142857143	0.368421052631579	21	27	15	0	0.0125117315748481	0.932059953006743
"110"	"EPH-ephrin mediated repulsion of cells"	48	48	18	0.375	48	48	17	0.354166666666667	0.280701754385965	16	21	2	0	0.0126611966175728	0.937109208824464
"343"	"Apoptotic cleavage of cellular proteins"	38	38	8	0.210526315789474	38	38	14	0.368421052631579	0.245614035087719	14	23	5	0	0.0132059925786439	0.968389359608265
"444"	"RORA activates circadian gene expression"	25	25	4	0.16	25	25	10	0.4	0.280701754385965	16	21	8	0	0.0132526433495866	0.968389359608265
"73"	"Interleukin-3, 5 and GM-CSF signaling"	45	45	19	0.422222222222222	45	45	16	0.355555555555556	0.43859649122807	25	32	15	0	0.0140141465486703	1
"344"	"Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants"	19	19	4	0.210526315789474	19	19	8	0.421052631578947	0.333333333333333	19	24	15	0	0.0141787613844924	1
"345"	"Signaling by FGFR1 fusion mutants"	19	19	4	0.210526315789474	19	19	8	0.421052631578947	0.368421052631579	21	26	15	0	0.0141787613844924	1
"411"	"Apoptotic execution  phase"	52	52	9	0.173076923076923	52	52	18	0.346153846153846	0.263157894736842	15	28	5	0	0.0143187735061594	1
"604"	"Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)"	114	114	12	0.105263157894737	114	114	35	0.307017543859649	0.456140350877193	26	51	8	0	0.014448004110766	1
"810"	"Regulation of insulin secretion"	77	77	3	0.038961038961039	77	77	25	0.324675324675325	0.403508771929825	23	34	3	0	0.0144849140575716	1
"227"	"PI3K/AKT activation"	103	103	29	0.281553398058252	103	103	32	0.310679611650485	0.614035087719298	35	60	15	0	0.0149671733389436	1
"778"	"Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"	42	42	2	0.0476190476190476	42	42	15	0.357142857142857	0.245614035087719	14	19	3	0	0.0154975782328285	1
"49"	"CD28 co-stimulation"	32	32	15	0.46875	32	32	12	0.375	0.403508771929825	23	28	15	0	0.0157461049732806	1
"67"	"GPVI-mediated activation cascade"	49	49	21	0.428571428571429	49	49	17	0.346938775510204	0.43859649122807	25	33	15	0	0.0159227011537433	1
"599"	"PPARA activates gene expression"	111	111	12	0.108108108108108	111	111	34	0.306306306306306	0.43859649122807	25	49	8	0	0.0160977500457162	1
"230"	"PI-3K cascade"	100	100	28	0.28	100	100	31	0.31	0.614035087719298	35	59	15	0	0.0166984769000693	1
"231"	"PI3K events in ERBB2 signaling"	100	100	28	0.28	100	100	31	0.31	0.614035087719298	35	59	15	0	0.0166984769000693	1
"232"	"PI3K events in ERBB4 signaling"	100	100	28	0.28	100	100	31	0.31	0.614035087719298	35	59	15	0	0.0166984769000693	1
"233"	"PI3K/AKT Signaling in Cancer"	100	100	28	0.28	100	100	31	0.31	0.614035087719298	35	59	15	0	0.0166984769000693	1
"234"	"PIP3 activates AKT signaling"	100	100	28	0.28	100	100	31	0.31	0.614035087719298	35	59	15	0	0.0166984769000693	1
"117"	"Organic cation transport"	8	8	3	0.375	8	8	4	0.5	0.105263157894737	6	6	2	0	0.0170452760005148	1
"535"	"Downregulation of ERBB4 signaling"	8	8	1	0.125	8	8	4	0.5	0.105263157894737	6	6	2	0	0.0170452760005148	1
"720"	"Translocation of GLUT4 to the plasma membrane"	60	60	4	0.0666666666666667	60	60	20	0.333333333333333	0.333333333333333	19	27	3	0	0.0174378139071834	1
"105"	"VEGFR2 mediated vascular permeability"	26	26	10	0.384615384615385	26	26	10	0.384615384615385	0.157894736842105	9	11	2	0	0.0184163350147177	1
"510"	"Transcriptional activation of mitochondrial biogenesis"	43	43	6	0.13953488372093	43	43	15	0.348837209302326	0.228070175438596	13	19	3	0	0.0196752258857503	1
"242"	"Condensation of Prometaphase Chromosomes"	11	11	3	0.272727272727273	11	11	5	0.454545454545455	0.12280701754386	7	7	2	0	0.0203053020574806	1
"765"	"Platelet degranulation"	79	79	4	0.0506329113924051	79	79	25	0.316455696202532	0.578947368421053	33	51	22	0	0.0203441217963534	1
"735"	"Glucagon signaling in metabolic regulation"	33	33	2	0.0606060606060606	33	33	12	0.363636363636364	0.210526315789474	12	14	3	0	0.020777115521825	1
"841"	"Cell death signalling via NRAGE, NRIF and NADE"	61	61	2	0.0327868852459016	61	61	20	0.327868852459016	0.228070175438596	13	24	2	0	0.0211292408006737	1
"133"	"Activation of Rac"	14	14	5	0.357142857142857	14	14	6	0.428571428571429	0.12280701754386	7	8	2	0	0.0214804083646076	1
"472"	"Glycogen breakdown (glycogenolysis)"	14	14	2	0.142857142857143	14	14	6	0.428571428571429	0.105263157894737	6	6	1	0	0.0214804083646076	1
"705"	"Mitotic Telophase/Cytokinesis"	14	14	1	0.0714285714285714	14	14	6	0.428571428571429	0.140350877192982	8	8	3	0	0.0214804083646076	1
"362"	"Phospholipase C-mediated cascade"	54	54	11	0.203703703703704	54	54	18	0.333333333333333	0.385964912280702	22	28	5	0	0.021786878162767	1
"953"	"Rho GTPase cycle"	121	121	1	0.00826446280991736	121	121	36	0.297520661157025	0.350877192982456	20	43	2	0	0.0222533007216114	1
"954"	"Signaling by Rho GTPases"	121	121	1	0.00826446280991736	121	121	36	0.297520661157025	0.350877192982456	20	43	2	0	0.0222533007216114	1
"423"	"Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity"	30	30	5	0.166666666666667	30	30	11	0.366666666666667	0.210526315789474	12	16	3	0	0.0228036876678388	1
"438"	"Trafficking of AMPA receptors"	30	30	5	0.166666666666667	30	30	11	0.366666666666667	0.210526315789474	12	16	3	0	0.0228036876678388	1
"832"	"Activated NOTCH1 Transmits Signal to the Nucleus"	30	30	1	0.0333333333333333	30	30	11	0.366666666666667	0.175438596491228	10	16	4	0	0.0228036876678388	1
"669"	"Opioid Signalling"	80	80	7	0.0875	80	80	25	0.3125	0.43859649122807	25	35	3	0	0.0238973714047419	1
"383"	"PI Metabolism"	51	51	10	0.196078431372549	51	51	17	0.333333333333333	0.508771929824561	29	39	15	0	0.0243687024720257	1
"297"	"Hedgehog 'off' state"	99	99	24	0.242424242424242	99	99	30	0.303030303030303	0.421052631578947	24	34	3	0	0.0248627054446806	1
"816"	"Kinesins"	27	27	1	0.037037037037037	27	27	10	0.37037037037037	0.157894736842105	9	11	2	0	0.024932737359646	1
"737"	"Response to elevated platelet cytosolic Ca2+"	84	84	5	0.0595238095238095	84	84	26	0.30952380952381	0.578947368421053	33	54	22	0	0.0249604703273987	1
"425"	"IRF3 mediated activation of type 1 IFN"	6	6	1	0.166666666666667	6	6	3	0.5	0.0526315789473684	3	3	1	0	0.0254777936895478	1
"16"	"GRB2 events in EGFR signaling"	21	21	12	0.571428571428571	21	21	8	0.380952380952381	0.175438596491228	10	11	3	0	0.0292571550538244	1
"387"	"Mitochondrial biogenesis"	52	52	10	0.192307692307692	52	52	17	0.326923076923077	0.228070175438596	13	21	3	0	0.0296892531010136	1
"722"	"Mitotic Prometaphase"	108	108	7	0.0648148148148148	108	108	32	0.296296296296296	0.403508771929825	23	36	2	0	0.0299494929071266	1
"37"	"Regulation of signaling by CBL"	18	18	9	0.5	18	18	7	0.388888888888889	0.350877192982456	20	23	15	0	0.0311966624853077	1
"595"	"cGMP effects"	18	18	2	0.111111111111111	18	18	7	0.388888888888889	0.140350877192982	8	9	2	0	0.0311966624853077	1
"11"	"ERK2 activation"	9	9	6	0.666666666666667	9	9	4	0.444444444444444	0.087719298245614	5	6	3	0	0.0313504519050123	1
"61"	"Nef and signal transduction"	9	9	4	0.444444444444444	9	9	4	0.444444444444444	0.0701754385964912	4	4	1	0	0.0313504519050123	1
"318"	"Role of Abl in Robo-Slit signaling"	9	9	2	0.222222222222222	9	9	4	0.444444444444444	0.12280701754386	7	7	2	0	0.0313504519050123	1
"718"	"Regulation of innate immune responses to cytosolic DNA"	15	15	1	0.0666666666666667	15	15	6	0.4	0.105263157894737	6	7	2	0	0.0326375127749561	1
"7"	"ERK activation"	12	12	9	0.75	12	12	5	0.416666666666667	0.105263157894737	6	7	3	0	0.0330360927684101	1
"286"	"ERKs are inactivated"	12	12	3	0.25	12	12	5	0.416666666666667	0.105263157894737	6	7	3	0	0.0330360927684101	1
"894"	"Muscle contraction"	49	49	1	0.0204081632653061	49	49	16	0.326530612244898	0.473684210526316	27	40	22	0	0.0332976056166822	1
"834"	"Cell-cell junction organization"	60	60	2	0.0333333333333333	60	60	19	0.316666666666667	0.403508771929825	23	27	3	0	0.0339749695347661	1
"235"	"Fc epsilon receptor (FCERI) signaling"	212	212	59	0.278301886792453	212	212	58	0.273584905660377	0.684210526315789	39	95	15	0	0.0354499452348412	1
"666"	"Factors involved in megakaryocyte development and platelet production"	125	125	11	0.088	125	125	36	0.288	0.456140350877193	26	46	8	0	0.0361449414679799	1
"766"	"Platelet homeostasis"	79	79	4	0.0506329113924051	79	79	24	0.30379746835443	0.350877192982456	20	31	3	0	0.0362694280530599	1
"686"	"Nitric oxide stimulates guanylate cyclase"	25	25	2	0.08	25	25	9	0.36	0.140350877192982	8	11	2	0	0.0363556073525202	1
"312"	"Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants"	57	57	13	0.228070175438596	57	57	18	0.315789473684211	0.385964912280702	22	34	8	0	0.0381391303246463	1
"313"	"Constitutive Signaling by NOTCH1 PEST Domain Mutants"	57	57	13	0.228070175438596	57	57	18	0.315789473684211	0.385964912280702	22	34	8	0	0.0381391303246463	1
"50"	"SHC1 events in ERBB2 signaling"	32	32	15	0.46875	32	32	11	0.34375	0.228070175438596	13	15	3	0	0.0382612104846999	1
"865"	"Glycosphingolipid metabolism"	39	39	1	0.0256410256410256	39	39	13	0.333333333333333	0.157894736842105	9	14	2	0	0.038336195182251	1
"350"	"FBXW7 Mutants and NOTCH1 in Cancer"	72	72	15	0.208333333333333	72	72	22	0.305555555555556	0.403508771929825	23	39	8	0	0.0391543007537323	1
"355"	"Signaling by NOTCH1"	72	72	15	0.208333333333333	72	72	22	0.305555555555556	0.403508771929825	23	39	8	0	0.0391543007537323	1
"356"	"Signaling by NOTCH1 HD Domain Mutants in Cancer"	72	72	15	0.208333333333333	72	72	22	0.305555555555556	0.403508771929825	23	39	8	0	0.0391543007537323	1
"357"	"Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer"	72	72	15	0.208333333333333	72	72	22	0.305555555555556	0.403508771929825	23	39	8	0	0.0391543007537323	1
"358"	"Signaling by NOTCH1 PEST Domain Mutants in Cancer"	72	72	15	0.208333333333333	72	72	22	0.305555555555556	0.403508771929825	23	39	8	0	0.0391543007537323	1
"359"	"Signaling by NOTCH1 in Cancer"	72	72	15	0.208333333333333	72	72	22	0.305555555555556	0.403508771929825	23	39	8	0	0.0391543007537323	1
"360"	"Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant"	72	72	15	0.208333333333333	72	72	22	0.305555555555556	0.403508771929825	23	39	8	0	0.0391543007537323	1
"19"	"SHC1 events in EGFR signaling"	22	22	12	0.545454545454545	22	22	8	0.363636363636364	0.175438596491228	10	11	3	0	0.0399262473356459	1
"795"	"Smooth Muscle Contraction"	22	22	1	0.0454545454545455	22	22	8	0.363636363636364	0.157894736842105	9	10	2	0	0.0399262473356459	1
"515"	"YAP1- and WWTR1 (TAZ)-stimulated gene expression"	29	29	4	0.137931034482759	29	29	10	0.344827586206897	0.192982456140351	11	13	3	0	0.0426782531792795	1
"25"	"Ephrin signaling"	19	19	10	0.526315789473684	19	19	7	0.368421052631579	0.140350877192982	8	8	2	0	0.0435733178313553	1
"670"	"Interferon gamma signaling"	92	92	8	0.0869565217391304	92	92	27	0.293478260869565	0.421052631578947	24	32	3	0	0.0451215249972707	1
"32"	"JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1"	16	16	8	0.5	16	16	6	0.375	0.105263157894737	6	7	2	0	0.0470746535265296	1
"392"	"Polo-like kinase mediated events"	16	16	3	0.1875	16	16	6	0.375	0.228070175438596	13	14	8	0	0.0470746535265296	1
"543"	"STING mediated induction of host immune responses"	16	16	2	0.125	16	16	6	0.375	0.087719298245614	5	6	1	0	0.0470746535265296	1
"726"	"Cell-extracellular matrix interactions"	16	16	1	0.0625	16	16	6	0.375	0.12280701754386	7	9	3	0	0.0470746535265296	1
"732"	"Trafficking of GluR2-containing AMPA receptors"	16	16	1	0.0625	16	16	6	0.375	0.157894736842105	9	10	3	0	0.0470746535265296	1
"175"	"Interleukin-1 signaling"	40	40	13	0.325	40	40	13	0.325	0.210526315789474	12	14	2	0	0.0472091381299944	1
"692"	"EGFR downregulation"	26	26	2	0.0769230769230769	26	26	9	0.346153846153846	0.157894736842105	9	10	2	0	0.0475676525636466	1
"179"	"G-protein beta:gamma signalling"	51	51	16	0.313725490196078	51	51	16	0.313725490196078	0.403508771929825	23	32	15	0	0.0481901872728105	1
"554"	"Nuclear Pore Complex (NPC) Disassembly"	33	33	4	0.121212121212121	33	33	11	0.333333333333333	0.105263157894737	6	12	2	0	0.0482521218920569	1
"453"	"Advanced glycosylation endproduct receptor signaling"	13	13	2	0.153846153846154	13	13	5	0.384615384615385	0.087719298245614	5	7	3	0	0.0499792897507996	1
"456"	"IRF3-mediated induction of type I IFN"	13	13	2	0.153846153846154	13	13	5	0.384615384615385	0.0701754385964912	4	5	1	0	0.0499792897507996	1
"3"	"Signalling to ERK5"	2	2	2	1	2	2	1	0.5	0.0175438596491228	1	1	1	0	0.0501917319040617	1
"29"	"Activation of CaMK IV"	2	2	1	0.5	2	2	1	0.5	0.0175438596491228	1	1	1	0	0.0501917319040617	1
"39"	"Stimulation of the cell death response by PAK-2p34"	2	2	1	0.5	2	2	1	0.5	0.0175438596491228	1	1	1	0	0.0501917319040617	1
"389"	"Signaling by Hedgehog"	136	136	26	0.191176470588235	136	136	38	0.279411764705882	0.473684210526316	27	44	3	0	0.0508189416505674	1
"628"	"Acetylcholine regulates insulin secretion"	10	10	1	0.1	10	10	4	0.4	0.12280701754386	7	7	3	0	0.0513397862645559	1
"639"	"Purine catabolism"	10	10	1	0.1	10	10	4	0.4	0.0701754385964912	4	4	1	0	0.0513397862645559	1
"51"	"GRB2 events in ERBB2 signaling"	30	30	14	0.466666666666667	30	30	10	0.333333333333333	0.228070175438596	13	14	3	0	0.0541845805806396	1
"838"	"Molecules associated with elastic fibres"	30	30	1	0.0333333333333333	30	30	10	0.333333333333333	0.192982456140351	11	12	3	0	0.0541845805806396	1
"410"	"Innate Immune System"	618	618	107	0.173139158576052	618	618	154	0.249190938511327	0.894736842105263	51	231	15	0	0.0547963865190428	1
"754"	"Generic Transcription Pathway"	483	483	26	0.0538302277432712	483	483	122	0.252587991718426	0.754385964912281	43	158	5	0	0.0553302165328076	1
"688"	"Fatty acid, triacylglycerol, and ketone body metabolism"	181	181	14	0.0773480662983425	181	181	49	0.270718232044199	0.491228070175439	28	67	8	0	0.0558407274018424	1
"174"	"Constitutive PI3K/AKT Signaling in Cancer"	86	86	28	0.325581395348837	86	86	25	0.290697674418605	0.596491228070175	34	51	15	0	0.0561059581903031	1
"464"	"Syndecan interactions"	20	20	3	0.15	20	20	7	0.35	0.12280701754386	7	9	3	0	0.0587880514625483	1
"33"	"MAP kinase activation in TLR cascade"	56	56	28	0.5	56	56	17	0.303571428571429	0.245614035087719	14	20	3	0	0.0597562473486083	1
"200"	"Recycling pathway of L1"	27	27	8	0.296296296296296	27	27	9	0.333333333333333	0.140350877192982	8	11	3	0	0.0608823085660001	1
"376"	"Signaling by FGFR mutants"	45	45	9	0.2	45	45	14	0.311111111111111	0.43859649122807	25	36	15	0	0.0611532052834265	1
"717"	"RMTs methylate histone arginines"	45	45	3	0.0666666666666667	45	45	14	0.311111111111111	0.263157894736842	15	17	2	0	0.0611532052834265	1
"511"	"Signaling by NOTCH"	122	122	17	0.139344262295082	122	122	34	0.278688524590164	0.56140350877193	32	58	8	0	0.0613926790312067	1
"561"	"Butyrate Response Factor 1 (BRF1) destabilizes mRNA"	17	17	2	0.117647058823529	17	17	6	0.352941176470588	0.105263157894737	6	7	2	0	0.0650081796982021	1
"101"	"NOD1/2 Signaling Pathway"	31	31	12	0.387096774193548	31	31	10	0.32258064516129	0.245614035087719	14	17	6	0	0.0675861746451366	1
"782"	"Neurotransmitter Release Cycle"	42	42	2	0.0476190476190476	42	42	13	0.30952380952381	0.210526315789474	12	16	3	0	0.0690249407490229	1
"785"	"Transcriptional regulation of pluripotent stem cells"	42	42	2	0.0476190476190476	42	42	13	0.30952380952381	0.228070175438596	13	16	3	0	0.0690249407490229	1
"71"	"Uptake and function of anthrax toxins"	14	14	6	0.428571428571429	14	14	5	0.357142857142857	0.087719298245614	5	5	1	0	0.0713534507904434	1
"479"	"Regulation of IFNG signaling"	14	14	2	0.142857142857143	14	14	5	0.357142857142857	0.12280701754386	7	7	2	0	0.0713534507904434	1
"598"	"G alpha (z) signalling events"	46	46	5	0.108695652173913	46	46	14	0.304347826086957	0.245614035087719	14	18	3	0	0.0726595166421304	1
"26"	"SOS-mediated signalling"	21	21	11	0.523809523809524	21	21	7	0.333333333333333	0.12280701754386	7	9	3	0	0.0769609107909937	1
"130"	"Interleukin-6 signaling"	11	11	4	0.363636363636364	11	11	4	0.363636363636364	0.12280701754386	7	7	3	0	0.0772018564371184	1
"131"	"Interleukin-7 signaling"	11	11	4	0.363636363636364	11	11	4	0.363636363636364	0.087719298245614	5	5	2	0	0.0772018564371184	1
"132"	"Transport of organic anions"	11	11	4	0.363636363636364	11	11	4	0.363636363636364	0.0526315789473684	3	5	2	0	0.0772018564371184	1
"401"	"Recruitment of NuMA to mitotic centrosomes"	11	11	2	0.181818181818182	11	11	4	0.363636363636364	0.0701754385964912	4	6	3	0	0.0772018564371184	1
"1"	"Abacavir transmembrane transport"	5	5	5	1	5	5	2	0.4	0.0350877192982456	2	2	1	0	0.078025807954748	1
"87"	"GRB7 events in ERBB2 signaling"	5	5	2	0.4	5	5	2	0.4	0.0350877192982456	2	2	1	0	0.078025807954748	1
"372"	"Nicotinamide salvaging"	5	5	1	0.2	5	5	2	0.4	0.0350877192982456	2	2	1	0	0.078025807954748	1
"687"	"Degradation of the extracellular matrix"	89	89	7	0.0786516853932584	89	89	25	0.280898876404494	0.385964912280702	22	35	3	0	0.0805701906792645	1
"115"	"Negative regulation of the PI3K/AKT network"	8	8	3	0.375	8	8	3	0.375	0.105263157894737	6	6	4	0	0.0809657659887825	1
"533"	"ChREBP activates metabolic gene expression"	8	8	1	0.125	8	8	3	0.375	0.0701754385964912	4	4	2	0	0.0809657659887825	1
"541"	"Regulation of cytoskeletal remodeling and cell spreading by IPP complex components"	8	8	1	0.125	8	8	3	0.375	0.0526315789473684	3	3	1	0	0.0809657659887825	1
"22"	"VEGFR2 mediated cell proliferation"	32	32	17	0.53125	32	32	10	0.3125	0.228070175438596	13	16	3	0	0.0829468701577465	1
"538"	"Oncogene Induced Senescence"	32	32	4	0.125	32	32	10	0.3125	0.228070175438596	13	15	3	0	0.0829468701577465	1
"46"	"SHC-related events triggered by IGF1R"	25	25	12	0.48	25	25	8	0.32	0.157894736842105	9	10	3	0	0.0864901257980396	1
"368"	"G0 and Early G1"	25	25	5	0.2	25	25	8	0.32	0.157894736842105	9	10	3	0	0.0864901257980396	1
"321"	"Tie2 Signaling"	18	18	4	0.222222222222222	18	18	6	0.333333333333333	0.333333333333333	19	21	15	0	0.086524599742771	1
"862"	"Gamma carboxylation, hypusine formation and arylsulfatase activation"	36	36	1	0.0277777777777778	36	36	11	0.305555555555556	0.192982456140351	11	13	2	0	0.0883727994349249	1
"283"	"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways"	51	51	13	0.254901960784314	51	51	15	0.294117647058824	0.315789473684211	18	23	6	0	0.0883998411331199	1
"532"	"Activation of gene expression by SREBF (SREBP)"	40	40	5	0.125	40	40	12	0.3	0.280701754385965	16	17	3	0	0.0928722898154934	1
"699"	"Interferon Signaling"	196	196	15	0.076530612244898	196	196	51	0.260204081632653	0.508771929824561	29	60	3	0	0.0958499942078597	1
"53"	"Recycling of bile acids and salts"	15	15	7	0.466666666666667	15	15	5	0.333333333333333	0.087719298245614	5	6	2	0	0.0971640761341017	1
"712"	"HDL-mediated lipid transport"	15	15	1	0.0666666666666667	15	15	5	0.333333333333333	0.105263157894737	6	6	2	0	0.0971640761341017	1
"38"	"SHC-mediated signalling"	22	22	11	0.5	22	22	7	0.318181818181818	0.140350877192982	8	9	3	0	0.0981235756226206	1
"77"	"TRAF6 Mediated Induction of proinflammatory cytokines"	75	75	31	0.413333333333333	75	75	21	0.28	0.298245614035088	17	26	3	0	0.0982218027900859	1
"158"	"G beta:gamma signalling through PI3Kgamma"	48	48	16	0.333333333333333	48	48	14	0.291666666666667	0.403508771929825	23	30	15	0	0.0997082765062114	1
"552"	"Cell surface interactions at the vascular wall"	99	99	12	0.121212121212121	99	99	27	0.272727272727273	0.56140350877193	32	46	15	0	0.10070305588335	1
"520"	"BMAL1:CLOCK,NPAS2 activates circadian gene expression"	37	37	5	0.135135135135135	37	37	11	0.297297297297297	0.298245614035088	17	22	8	0	0.105284173532088	1
"72"	"Signaling by Leptin"	26	26	11	0.423076923076923	26	26	8	0.307692307692308	0.175438596491228	10	12	3	0	0.107096141039777	1
"311"	"TAK1 activates NFkB by phosphorylation and activation of IKKs complex"	26	26	6	0.230769230769231	26	26	8	0.307692307692308	0.175438596491228	10	11	2	0	0.107096141039777	1
"30"	"CD28 dependent Vav1 pathway"	12	12	6	0.5	12	12	4	0.333333333333333	0.0526315789473684	3	4	1	0	0.108748830486196	1
"427"	"Inhibition of replication initiation of damaged DNA by RB1/E2F1"	12	12	2	0.166666666666667	12	12	4	0.333333333333333	0.12280701754386	7	7	4	0	0.108748830486196	1
"770"	"Resolution of Sister Chromatid Cohesion"	100	100	5	0.05	100	100	27	0.27	0.333333333333333	19	29	2	0	0.111232451668496	1
"224"	"IGF1R signaling cascade"	92	92	26	0.282608695652174	92	92	25	0.271739130434783	0.526315789473684	30	51	15	0	0.111384758521367	1
"226"	"Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"	92	92	26	0.282608695652174	92	92	25	0.271739130434783	0.526315789473684	30	51	15	0	0.111384758521367	1
"363"	"Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"	45	45	9	0.2	45	45	13	0.288888888888889	0.210526315789474	12	18	3	0	0.112619524839517	1
"377"	"Signaling by FGFR1 mutants"	30	30	6	0.2	30	30	9	0.3	0.368421052631579	21	27	15	0	0.114105472630194	1
"636"	"Inactivation, recovery and regulation of the phototransduction cascade"	30	30	3	0.1	30	30	9	0.3	0.157894736842105	9	11	3	0	0.114105472630194	1
"898"	"Glycogen storage diseases"	257	257	5	0.0194552529182879	257	257	65	0.252918287937743	0.614035087719298	35	70	3	0	0.115351429629	1
"899"	"Metabolism of carbohydrates"	257	257	5	0.0194552529182879	257	257	65	0.252918287937743	0.614035087719298	35	70	3	0	0.115351429629	1
"900"	"Myoclonic epilepsy of Lafora"	257	257	5	0.0194552529182879	257	257	65	0.252918287937743	0.614035087719298	35	70	3	0	0.115351429629	1
"650"	"Regulation of cholesterol biosynthesis by SREBP (SREBF)"	53	53	5	0.0943396226415094	53	53	15	0.283018867924528	0.350877192982456	20	24	3	0	0.117420752324749	1
"24"	"Signalling to RAS"	34	34	18	0.529411764705882	34	34	10	0.294117647058824	0.210526315789474	12	13	3	0	0.119618330035802	1
"59"	"EGFR Transactivation by Gastrin"	9	9	4	0.444444444444444	9	9	3	0.333333333333333	0.105263157894737	6	6	3	0	0.120658017255798	1
"592"	"Removal of aminoterminal propeptides from gamma-carboxylated proteins"	9	9	1	0.111111111111111	9	9	3	0.333333333333333	0.0701754385964912	4	4	2	0	0.120658017255798	1
"27"	"ARMS-mediated activation"	23	23	12	0.521739130434783	23	23	7	0.304347826086957	0.140350877192982	8	9	3	0	0.122219365218531	1
"186"	"Endogenous sterols"	23	23	7	0.304347826086957	23	23	7	0.304347826086957	0.105263157894737	6	9	2	0	0.122219365218531	1
"525"	"Double-Strand Break Repair"	23	23	3	0.130434782608696	23	23	7	0.304347826086957	0.12280701754386	7	8	2	0	0.122219365218531	1
"526"	"Downregulation of SMAD2/3:SMAD4 transcriptional activity"	23	23	3	0.130434782608696	23	23	7	0.304347826086957	0.140350877192982	8	9	2	0	0.122219365218531	1
"206"	"IRS-related events triggered by IGF1R"	89	89	26	0.292134831460674	89	89	24	0.269662921348315	0.508771929824561	29	50	15	0	0.123310887246088	1
"394"	"TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)"	16	16	3	0.1875	16	16	5	0.3125	0.087719298245614	5	6	2	0	0.127217729698645	1
"537"	"Metabolism of Angiotensinogen to Angiotensins"	16	16	2	0.125	16	16	5	0.3125	0.105263157894737	6	7	2	0	0.127217729698645	1
"731"	"TRAF6 mediated induction of TAK1 complex"	16	16	1	0.0625	16	16	5	0.3125	0.087719298245614	5	6	2	0	0.127217729698645	1
"12"	"Formation of apoptosome"	3	3	2	0.666666666666667	3	3	1	0.333333333333333	0.0175438596491228	1	1	1	0	0.12810108951422	1
"154"	"CaMK IV-mediated phosphorylation of CREB"	3	3	1	0.333333333333333	3	3	1	0.333333333333333	0.0175438596491228	1	1	1	0	0.12810108951422	1
"159"	"Inhibition of TSC complex formation by PKB"	3	3	1	0.333333333333333	3	3	1	0.333333333333333	0.0175438596491228	1	1	1	0	0.12810108951422	1
"160"	"Interactions of Tat with host cellular proteins"	3	3	1	0.333333333333333	3	3	1	0.333333333333333	0.0175438596491228	1	1	1	0	0.12810108951422	1
"162"	"Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha"	3	3	1	0.333333333333333	3	3	1	0.333333333333333	0.0175438596491228	1	1	1	0	0.12810108951422	1
"164"	"Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes"	3	3	1	0.333333333333333	3	3	1	0.333333333333333	0.0175438596491228	1	1	1	0	0.12810108951422	1
"166"	"Signalling to STAT3"	3	3	1	0.333333333333333	3	3	1	0.333333333333333	0.0526315789473684	3	3	3	0	0.12810108951422	1
"168"	"The NLRP1 inflammasome"	3	3	1	0.333333333333333	3	3	1	0.333333333333333	0.0350877192982456	2	2	2	0	0.12810108951422	1
"2"	"RSK activation"	6	6	6	1	6	6	2	0.333333333333333	0.0526315789473684	3	4	3	0	0.130573822219949	1
"161"	"Klotho-mediated ligand binding"	6	6	2	0.333333333333333	6	6	2	0.333333333333333	0.0350877192982456	2	2	1	0	0.130573822219949	1
"428"	"Nonhomologous End-joining (NHEJ)"	6	6	1	0.166666666666667	6	6	2	0.333333333333333	0.0350877192982456	2	2	1	0	0.130573822219949	1
"435"	"Synthesis of 15-eicosatetraenoic acid derivatives"	6	6	1	0.166666666666667	6	6	2	0.333333333333333	0.0350877192982456	2	2	1	0	0.130573822219949	1
"668"	"Orphan transporters"	114	114	10	0.087719298245614	114	114	30	0.263157894736842	0.385964912280702	22	39	3	0	0.13197166335817	1
"643"	"The phototransduction cascade"	31	31	3	0.0967741935483871	31	31	9	0.290322580645161	0.157894736842105	9	11	3	0	0.136257519289745	1
"95"	"TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation"	86	86	34	0.395348837209302	86	86	23	0.267441860465116	0.298245614035088	17	28	3	0	0.136491187298636	1
"768"	"Fatty Acyl-CoA Biosynthesis"	20	20	1	0.05	20	20	6	0.3	0.12280701754386	7	7	2	0	0.140005686429546	1
"346"	"Fcgamma receptor (FCGR) dependent phagocytosis"	119	119	25	0.210084033613445	119	119	31	0.260504201680672	0.578947368421053	33	58	15	0	0.14253214543934	1
"104"	"Downregulation of ERBB2:ERBB3 signaling"	13	13	5	0.384615384615385	13	13	4	0.307692307692308	0.0701754385964912	4	4	1	0	0.145479793445819	1
"308"	"Organic cation/anion/zwitterion transport"	13	13	3	0.230769230769231	13	13	4	0.307692307692308	0.105263157894737	6	6	2	0	0.145479793445819	1
"458"	"Platelet Adhesion to exposed collagen"	13	13	2	0.153846153846154	13	13	4	0.307692307692308	0.0701754385964912	4	5	2	0	0.145479793445819	1
"956"	"Processing of Capped Intron-Containing Pre-mRNA"	144	144	1	0.00694444444444444	144	144	37	0.256944444444444	0.385964912280702	22	42	4	0	0.145903306922754	1
"788"	"Vasopressin regulates renal water homeostasis via Aquaporins"	43	43	2	0.0465116279069767	43	43	12	0.27906976744186	0.210526315789474	12	14	3	0	0.147043230180575	1
"196"	"NOTCH1 Intracellular Domain Regulates Transcription"	47	47	14	0.297872340425532	47	47	13	0.276595744680851	0.385964912280702	22	28	8	0	0.149022566675299	1
"351"	"Growth hormone receptor signaling"	24	24	5	0.208333333333333	24	24	7	0.291666666666667	0.175438596491228	10	12	3	0	0.149108198248971	1
"905"	"GABA receptor activation"	55	55	1	0.0181818181818182	55	55	15	0.272727272727273	0.280701754385965	16	18	3	0	0.151451775947891	1
"665"	"RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways"	79	79	7	0.0886075949367089	79	79	21	0.265822784810127	0.491228070175439	28	41	8	0	0.151626065073214	1
"524"	"Cell Cycle"	518	518	68	0.131274131274131	518	518	125	0.241312741312741	0.894736842105263	51	165	8	0	0.151947221954179	1
"802"	"Sphingolipid metabolism"	71	71	3	0.0422535211267606	71	71	19	0.267605633802817	0.210526315789474	12	21	2	0	0.152375485261597	1
"14"	"RAF/MAP kinase cascade"	17	17	10	0.588235294117647	17	17	5	0.294117647058824	0.105263157894737	6	7	3	0	0.161150211517069	1
"48"	"activated TAK1 mediates p38 MAPK activation"	17	17	8	0.470588235294118	17	17	5	0.294117647058824	0.105263157894737	6	6	2	0	0.161150211517069	1
"301"	"Metabolism of nitric oxide"	17	17	4	0.235294117647059	17	17	5	0.294117647058824	0.087719298245614	5	5	1	0	0.161150211517069	1
"305"	"eNOS activation and regulation"	17	17	4	0.235294117647059	17	17	5	0.294117647058824	0.087719298245614	5	5	1	0	0.161150211517069	1
"563"	"Homologous Recombination Repair"	17	17	2	0.117647058823529	17	17	5	0.294117647058824	0.105263157894737	6	6	2	0	0.161150211517069	1
"564"	"Homologous recombination repair of replication-independent double-strand breaks"	17	17	2	0.117647058823529	17	17	5	0.294117647058824	0.105263157894737	6	6	2	0	0.161150211517069	1
"742"	"Tristetraprolin (TTP) destabilizes mRNA"	17	17	1	0.0588235294117647	17	17	5	0.294117647058824	0.105263157894737	6	6	2	0	0.161150211517069	1
"925"	"Regulatory RNA pathways"	100	100	1	0.01	100	100	26	0.26	0.280701754385965	16	30	3	0	0.161360188299361	1
"114"	"MyD88:Mal cascade initiated on plasma membrane"	96	96	36	0.375	96	96	25	0.260416666666667	0.298245614035088	17	30	3	0	0.162630675393315	1
"119"	"Toll Like Receptor 2 (TLR2) Cascade"	96	96	36	0.375	96	96	25	0.260416666666667	0.298245614035088	17	30	3	0	0.162630675393315	1
"120"	"Toll Like Receptor TLR1:TLR2 Cascade"	96	96	36	0.375	96	96	25	0.260416666666667	0.298245614035088	17	30	3	0	0.162630675393315	1
"121"	"Toll Like Receptor TLR6:TLR2 Cascade"	96	96	36	0.375	96	96	25	0.260416666666667	0.298245614035088	17	30	3	0	0.162630675393315	1
"125"	"Toll Like Receptor 9 (TLR9) Cascade"	92	92	34	0.369565217391304	92	92	24	0.260869565217391	0.298245614035088	17	30	3	0	0.163853132666832	1
"102"	"MyD88 dependent cascade initiated on endosome"	88	88	34	0.386363636363636	88	88	23	0.261363636363636	0.298245614035088	17	28	3	0	0.165017916014379	1
"103"	"Toll Like Receptor 7/8 (TLR7/8) Cascade"	88	88	34	0.386363636363636	88	88	23	0.261363636363636	0.298245614035088	17	28	3	0	0.165017916014379	1
"10"	"ERK1 activation"	10	10	7	0.7	10	10	3	0.3	0.0526315789473684	3	3	1	0	0.166870171249961	1
"28"	"Abacavir transport and metabolism"	10	10	5	0.5	10	10	3	0.3	0.0526315789473684	3	3	1	0	0.166870171249961	1
"373"	"Regulation of Rheb GTPase activity by AMPK"	10	10	2	0.2	10	10	3	0.3	0.0526315789473684	3	4	2	0	0.166870171249961	1
"641"	"TRIF-mediated programmed cell death"	10	10	1	0.1	10	10	3	0.3	0.0526315789473684	3	3	1	0	0.166870171249961	1
"65"	"Signalling to ERKs"	44	44	19	0.431818181818182	44	44	12	0.272727272727273	0.228070175438596	13	15	3	0	0.168193579846329	1
"274"	"Signaling by the B Cell Receptor (BCR)"	209	209	55	0.263157894736842	209	209	52	0.248803827751196	0.684210526315789	39	84	15	0	0.169879120246974	1
"633"	"HDACs deacetylate histones"	60	60	6	0.1	60	60	16	0.266666666666667	0.210526315789474	12	18	2	0	0.170249091748382	1
"66"	"ERK/MAPK targets"	21	21	9	0.428571428571429	21	21	6	0.285714285714286	0.12280701754386	7	8	3	0	0.171528074248823	1
"45"	"SHC-related events"	25	25	12	0.48	25	25	7	0.28	0.140350877192982	8	9	3	0	0.178575526461174	1
"443"	"Effects of PIP2 hydrolysis"	25	25	4	0.16	25	25	7	0.28	0.12280701754386	7	10	3	0	0.178575526461174	1
"557"	"Cellular response to hypoxia"	25	25	3	0.12	25	25	7	0.28	0.263157894736842	15	15	8	0	0.178575526461174	1
"558"	"Regulation of Hypoxia-inducible Factor (HIF) by oxygen"	25	25	3	0.12	25	25	7	0.28	0.263157894736842	15	15	8	0	0.178575526461174	1
"205"	"IRS-mediated signalling"	85	85	25	0.294117647058824	85	85	22	0.258823529411765	0.491228070175439	28	45	15	0	0.181959202686338	1
"415"	"The role of Nef in HIV-1 replication and disease pathogenesis"	29	29	5	0.172413793103448	29	29	8	0.275862068965517	0.192982456140351	11	11	3	0	0.183396709938527	1
"626"	"SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription"	29	29	3	0.103448275862069	29	29	8	0.275862068965517	0.140350877192982	8	10	3	0	0.183396709938527	1
"407"	"G2/M Transition"	114	114	20	0.175438596491228	114	114	29	0.254385964912281	0.456140350877193	26	43	8	0	0.184278632814109	1
"749"	"Antiviral mechanism by IFN-stimulated genes"	73	73	4	0.0547945205479452	73	73	19	0.26027397260274	0.192982456140351	11	24	2	0	0.186199449935135	1
"750"	"ISG15 antiviral mechanism"	73	73	4	0.0547945205479452	73	73	19	0.26027397260274	0.192982456140351	11	24	2	0	0.186199449935135	1
"220"	"Signal attenuation"	14	14	4	0.285714285714286	14	14	4	0.285714285714286	0.087719298245614	5	6	3	0	0.186661094921027	1
"553"	"Metabolism of steroid hormones and vitamin D"	33	33	4	0.121212121212121	33	33	9	0.272727272727273	0.157894736842105	9	11	2	0	0.18666154046242	1
"555"	"Steroid hormones"	33	33	4	0.121212121212121	33	33	9	0.272727272727273	0.157894736842105	9	11	2	0	0.18666154046242	1
"736"	"Negative regulators of RIG-I/MDA5 signaling"	33	33	2	0.0606060606060606	33	33	9	0.272727272727273	0.315789473684211	18	19	6	0	0.18666154046242	1
"551"	"Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer"	41	41	5	0.121951219512195	41	41	11	0.268292682926829	0.192982456140351	11	15	3	0	0.190102941052357	1
"772"	"Pre-NOTCH Transcription and Translation"	41	41	2	0.0487804878048781	41	41	11	0.268292682926829	0.421052631578947	24	28	8	0	0.190102941052357	1
"825"	"Pre-NOTCH Expression and Processing"	57	57	2	0.0350877192982456	57	57	15	0.263157894736842	0.43859649122807	25	33	8	0	0.190232591007577	1
"68"	"MEK activation"	7	7	3	0.428571428571429	7	7	2	0.285714285714286	0.0350877192982456	2	2	1	0	0.191750048138923	1
"69"	"RAF phosphorylates MEK"	7	7	3	0.428571428571429	7	7	2	0.285714285714286	0.0350877192982456	2	2	1	0	0.191750048138923	1
"216"	"FGFR3b ligand binding and activation"	7	7	2	0.285714285714286	7	7	2	0.285714285714286	0.105263157894737	6	6	5	0	0.191750048138923	1
"222"	"eNOS activation"	7	7	2	0.285714285714286	7	7	2	0.285714285714286	0.0350877192982456	2	2	1	0	0.191750048138923	1
"473"	"Homologous DNA pairing and strand exchange"	7	7	1	0.142857142857143	7	7	2	0.285714285714286	0.0526315789473684	3	3	2	0	0.191750048138923	1
"851"	"Membrane Trafficking"	190	190	6	0.0315789473684211	190	190	47	0.247368421052632	0.508771929824561	29	63	5	0	0.191758760425737	1
"409"	"beta-catenin independent WNT signaling"	144	144	25	0.173611111111111	144	144	36	0.25	0.456140350877193	26	44	3	0	0.195236412626115	1
"591"	"Removal of DNA patch containing abasic residue"	18	18	2	0.111111111111111	18	18	5	0.277777777777778	0.087719298245614	5	5	1	0	0.198463017404217	1
"593"	"Resolution of AP sites via the multiple-nucleotide patch replacement pathway"	18	18	2	0.111111111111111	18	18	5	0.277777777777778	0.087719298245614	5	5	1	0	0.198463017404217	1
"94"	"MyD88 cascade initiated on plasma membrane"	86	86	34	0.395348837209302	86	86	22	0.255813953488372	0.298245614035088	17	27	3	0	0.198558636875498	1
"96"	"Toll Like Receptor 10 (TLR10) Cascade"	86	86	34	0.395348837209302	86	86	22	0.255813953488372	0.298245614035088	17	27	3	0	0.198558636875498	1
"97"	"Toll Like Receptor 5 (TLR5) Cascade"	86	86	34	0.395348837209302	86	86	22	0.255813953488372	0.298245614035088	17	27	3	0	0.198558636875498	1
"204"	"Downstream signaling events of B Cell Receptor (BCR)"	170	170	50	0.294117647058824	170	170	42	0.247058823529412	0.666666666666667	38	71	15	0	0.20471252885164	1
"20"	"Signalling to p38 via RIT and RIN"	22	22	12	0.545454545454545	22	22	6	0.272727272727273	0.12280701754386	7	8	3	0	0.20578350694105	1
"791"	"Common Pathway"	22	22	1	0.0454545454545455	22	22	6	0.272727272727273	0.12280701754386	7	7	2	0	0.20578350694105	1
"571"	"Loss of Function of SMAD2/3 in Cancer"	70	70	8	0.114285714285714	70	70	18	0.257142857142857	0.280701754385965	16	23	3	0	0.206275041040451	1
"572"	"Loss of Function of SMAD4 in Cancer"	70	70	8	0.114285714285714	70	70	18	0.257142857142857	0.280701754385965	16	23	3	0	0.206275041040451	1
"573"	"Loss of Function of TGFBR1 in Cancer"	70	70	8	0.114285714285714	70	70	18	0.257142857142857	0.280701754385965	16	23	3	0	0.206275041040451	1
"574"	"Loss of Function of TGFBR2 in Cancer"	70	70	8	0.114285714285714	70	70	18	0.257142857142857	0.280701754385965	16	23	3	0	0.206275041040451	1
"576"	"SMAD2/3 MH2 Domain Mutants in Cancer"	70	70	8	0.114285714285714	70	70	18	0.257142857142857	0.280701754385965	16	23	3	0	0.206275041040451	1
"577"	"SMAD2/3 Phosphorylation Motif Mutants in Cancer"	70	70	8	0.114285714285714	70	70	18	0.257142857142857	0.280701754385965	16	23	3	0	0.206275041040451	1
"578"	"SMAD4 MH2 Domain Mutants in Cancer"	70	70	8	0.114285714285714	70	70	18	0.257142857142857	0.280701754385965	16	23	3	0	0.206275041040451	1
"579"	"Signaling by TGF-beta Receptor Complex"	70	70	8	0.114285714285714	70	70	18	0.257142857142857	0.280701754385965	16	23	3	0	0.206275041040451	1
"580"	"Signaling by TGF-beta Receptor Complex in Cancer"	70	70	8	0.114285714285714	70	70	18	0.257142857142857	0.280701754385965	16	23	3	0	0.206275041040451	1
"581"	"TGFBR1 KD Mutants in Cancer"	70	70	8	0.114285714285714	70	70	18	0.257142857142857	0.280701754385965	16	23	3	0	0.206275041040451	1
"582"	"TGFBR1 LBD Mutants in Cancer"	70	70	8	0.114285714285714	70	70	18	0.257142857142857	0.280701754385965	16	23	3	0	0.206275041040451	1
"583"	"TGFBR2 Kinase Domain Mutants in Cancer"	70	70	8	0.114285714285714	70	70	18	0.257142857142857	0.280701754385965	16	23	3	0	0.206275041040451	1
"584"	"TGFBR2 MSI Frameshift Mutants in Cancer"	70	70	8	0.114285714285714	70	70	18	0.257142857142857	0.280701754385965	16	23	3	0	0.206275041040451	1
"655"	"Cytosolic sensors of pathogen-associated DNA"	66	66	6	0.0909090909090909	66	66	17	0.257575757575758	0.333333333333333	19	30	8	0	0.208048409839403	1
"178"	"Toll Like Receptor 4 (TLR4) Cascade"	124	124	39	0.314516129032258	124	124	31	0.25	0.368421052631579	21	38	3	0	0.208072724016094	1
"137"	"MyD88-independent cascade"	99	99	35	0.353535353535354	99	99	25	0.252525252525253	0.333333333333333	19	32	3	0	0.208361192474344	1
"138"	"TRIF-mediated TLR3/TLR4 signaling"	99	99	35	0.353535353535354	99	99	25	0.252525252525253	0.333333333333333	19	32	3	0	0.208361192474344	1
"139"	"Toll Like Receptor 3 (TLR3) Cascade"	99	99	35	0.353535353535354	99	99	25	0.252525252525253	0.333333333333333	19	32	3	0	0.208361192474344	1
"388"	"ZBP1(DAI) mediated induction of type I IFNs"	26	26	5	0.192307692307692	26	26	7	0.269230769230769	0.12280701754386	7	9	2	0	0.210344142204017	1
"467"	"Regulation of actin dynamics for phagocytic cup formation"	95	95	14	0.147368421052632	95	95	24	0.252631578947368	0.421052631578947	24	34	4	0	0.21085124620746	1
"904"	"Golgi Associated Vesicle Biogenesis"	54	54	1	0.0185185185185185	54	54	14	0.259259259259259	0.263157894736842	15	19	5	0	0.212634867221748	1
"837"	"Lipoprotein metabolism"	30	30	1	0.0333333333333333	30	30	8	0.266666666666667	0.175438596491228	10	11	3	0	0.21309295449924	1
"413"	"Mitotic G2-G2/M phases"	116	116	20	0.172413793103448	116	116	29	0.25	0.456140350877193	26	43	8	0	0.213498464244813	1
"507"	"Nuclear Envelope Breakdown"	50	50	7	0.14	50	50	13	0.26	0.157894736842105	9	16	3	0	0.213792386652094	1
"18"	"DSCAM interactions"	11	11	6	0.545454545454545	11	11	3	0.272727272727273	0.0526315789473684	3	3	1	0	0.21810920828587	1
"656"	"Dimerization of procaspase-8"	11	11	1	0.0909090909090909	11	11	3	0.272727272727273	0.0526315789473684	3	3	1	0	0.21810920828587	1
"657"	"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins"	11	11	1	0.0909090909090909	11	11	3	0.272727272727273	0.0701754385964912	4	4	2	0	0.21810920828587	1
"658"	"Heme biosynthesis"	11	11	1	0.0909090909090909	11	11	3	0.272727272727273	0.0526315789473684	3	3	1	0	0.21810920828587	1
"660"	"Nicotinate metabolism"	11	11	1	0.0909090909090909	11	11	3	0.272727272727273	0.0526315789473684	3	3	1	0	0.21810920828587	1
"661"	"Regulation by c-FLIP"	11	11	1	0.0909090909090909	11	11	3	0.272727272727273	0.0526315789473684	3	3	1	0	0.21810920828587	1
"6"	"AKT-mediated inactivation of FOXO1A"	4	4	3	0.75	4	4	1	0.25	0.0175438596491228	1	1	1	0	0.218797877083466	1
"31"	"CREB phosphorylation through the activation of CaMKK"	4	4	2	0.5	4	4	1	0.25	0.0175438596491228	1	1	1	0	0.218797877083466	1
"34"	"Neurophilin interactions with VEGF and VEGFR"	4	4	2	0.5	4	4	1	0.25	0.0175438596491228	1	1	1	0	0.218797877083466	1
"291"	"Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes"	4	4	1	0.25	4	4	1	0.25	0.0701754385964912	4	4	4	0	0.218797877083466	1
"292"	"Processing of DNA ends prior to end rejoining"	4	4	1	0.25	4	4	1	0.25	0.0175438596491228	1	1	1	0	0.218797877083466	1
"293"	"Proton/oligonucleotide cotransporters"	4	4	1	0.25	4	4	1	0.25	0.0175438596491228	1	1	1	0	0.218797877083466	1
"955"	"Post-translational protein modification"	278	278	2	0.00719424460431655	278	278	67	0.241007194244604	0.596491228070175	34	95	9	0	0.221314663895495	1
"549"	"M Phase"	266	266	33	0.12406015037594	266	266	64	0.240601503759398	0.631578947368421	36	80	4	0	0.230172458881045	1
"225"	"Insulin receptor signalling cascade"	92	92	26	0.282608695652174	92	92	23	0.25	0.508771929824561	29	46	15	0	0.230829848843206	1
"522"	"Fatty acids"	15	15	2	0.133333333333333	15	15	4	0.266666666666667	0.087719298245614	5	5	2	0	0.23140960431449	1
"523"	"Prolactin receptor signaling"	15	15	2	0.133333333333333	15	15	4	0.266666666666667	0.0526315789473684	3	4	1	0	0.23140960431449	1
"201"	"IRS-related events"	88	88	26	0.295454545454545	88	88	22	0.25	0.491228070175439	28	45	15	0	0.233873023688277	1
"331"	"Signaling by BMP"	23	23	5	0.217391304347826	23	23	6	0.260869565217391	0.140350877192982	8	8	2	0	0.242342818944652	1
"416"	"HSF1-dependent transactivation"	35	35	6	0.171428571428571	35	35	9	0.257142857142857	0.280701754385965	16	18	8	0	0.244085987271229	1
"62"	"Prolonged ERK activation events"	27	27	12	0.444444444444444	27	27	7	0.259259259259259	0.140350877192982	8	9	3	0	0.244087756910271	1
"349"	"Centrosome maturation"	72	72	15	0.208333333333333	72	72	18	0.25	0.280701754385965	16	24	3	0	0.246450537650842	1
"353"	"Recruitment of mitotic centrosome proteins and complexes"	72	72	15	0.208333333333333	72	72	18	0.25	0.280701754385965	16	24	3	0	0.246450537650842	1
"470"	"Cell Cycle, Mitotic"	445	445	64	0.143820224719101	445	445	105	0.235955056179775	0.807017543859649	46	136	8	0	0.247476014492424	1
"672"	"Mitotic Prophase"	106	106	9	0.0849056603773585	106	106	26	0.245283018867925	0.385964912280702	22	36	4	0	0.255774715062981	1
"824"	"Meiosis"	85	85	3	0.0352941176470588	85	85	21	0.247058823529412	0.403508771929825	23	29	7	0	0.256164967136224	1
"113"	"Glucocorticoid biosynthesis"	8	8	3	0.375	8	8	2	0.25	0.0526315789473684	3	3	2	0	0.258220617429008	1
"122"	"WNT mediated activation of DVL"	8	8	3	0.375	8	8	2	0.25	0.0350877192982456	2	2	1	0	0.258220617429008	1
"536"	"Ligand-receptor interactions"	8	8	1	0.125	8	8	2	0.25	0.0701754385964912	4	4	2	0	0.258220617429008	1
"542"	"Release of Hh-Np from the secreting cell"	8	8	1	0.125	8	8	2	0.25	0.0350877192982456	2	2	1	0	0.258220617429008	1
"545"	"Synthesis of PG"	8	8	1	0.125	8	8	2	0.25	0.0350877192982456	2	2	1	0	0.258220617429008	1
"546"	"Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)"	8	8	1	0.125	8	8	2	0.25	0.0526315789473684	3	3	2	0	0.258220617429008	1
"548"	"Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus"	8	8	1	0.125	8	8	2	0.25	0.0526315789473684	3	3	2	0	0.258220617429008	1
"682"	"Metabolism of lipids and lipoproteins"	569	569	46	0.0808435852372583	569	569	133	0.233743409490334	0.842105263157895	48	189	15	0	0.263867810811537	1
"151"	"Activated TLR4 signalling"	115	115	39	0.339130434782609	115	115	28	0.243478260869565	0.333333333333333	19	35	3	0	0.265164849580351	1
"129"	"FRS2-mediated cascade"	44	44	16	0.363636363636364	44	44	11	0.25	0.263157894736842	15	17	5	0	0.269071903966193	1
"380"	"Uptake and actions of bacterial toxins"	40	40	8	0.2	40	40	10	0.25	0.140350877192982	8	10	1	0	0.272084034588973	1
"36"	"PECAM1 interactions"	12	12	6	0.5	12	12	3	0.25	0.0526315789473684	3	3	1	0	0.272789397185707	1
"287"	"Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis"	12	12	3	0.25	12	12	3	0.25	0.0350877192982456	2	3	1	0	0.272789397185707	1
"429"	"P2Y receptors"	12	12	2	0.166666666666667	12	12	3	0.25	0.0526315789473684	3	3	1	0	0.272789397185707	1
"674"	"Caspase-mediated cleavage of cytoskeletal proteins"	12	12	1	0.0833333333333333	12	12	3	0.25	0.140350877192982	8	9	5	0	0.272789397185707	1
"678"	"Processive synthesis on the C-strand of the telomere"	12	12	1	0.0833333333333333	12	12	3	0.25	0.0526315789473684	3	3	1	0	0.272789397185707	1
"328"	"Signaling by Robo receptor"	32	32	7	0.21875	32	32	8	0.25	0.175438596491228	10	11	2	0	0.277409284716503	1
"391"	"Activation of Matrix Metalloproteinases"	32	32	6	0.1875	32	32	8	0.25	0.175438596491228	10	11	3	0	0.277409284716503	1
"17"	"Regulation of KIT signaling"	16	16	9	0.5625	16	16	4	0.25	0.105263157894737	6	6	3	0	0.278769547321692	1
"118"	"Spry regulation of FGF signaling"	16	16	6	0.375	16	16	4	0.25	0.087719298245614	5	6	3	0	0.278769547321692	1
"285"	"CRMPs in Sema3A signaling"	16	16	4	0.25	16	16	4	0.25	0.0701754385964912	4	4	1	0	0.278769547321692	1
"294"	"Rap1 signalling"	16	16	4	0.25	16	16	4	0.25	0.105263157894737	6	6	3	0	0.278769547321692	1
"70"	"SHC1 events in ERBB4 signaling"	28	28	12	0.428571428571429	28	28	7	0.25	0.157894736842105	9	10	3	0	0.279445331725501	1
"76"	"Nuclear Events (kinase and transcription factor activation)"	24	24	10	0.416666666666667	24	24	6	0.25	0.12280701754386	7	8	3	0	0.280733545113462	1
"534"	"DARPP-32 events"	24	24	3	0.125	24	24	6	0.25	0.087719298245614	5	7	2	0	0.280733545113462	1
"462"	"Base Excision Repair"	20	20	3	0.15	20	20	5	0.25	0.087719298245614	5	5	1	0	0.28080198554487	1
"463"	"Resolution of Abasic Sites (AP sites)"	20	20	3	0.15	20	20	5	0.25	0.087719298245614	5	5	1	0	0.28080198554487	1
"530"	"Immune System"	1216	1216	153	0.125822368421053	1216	1216	279	0.229440789473684	0.964912280701754	55	394	15	0	0.298300618425766	1
"347"	"Loss of Nlp from mitotic centrosomes"	62	62	13	0.209677419354839	62	62	15	0.241935483870968	0.280701754385965	16	21	3	0	0.304343521411108	1
"348"	"Loss of proteins required for interphase microtubule organization from the centrosome"	62	62	13	0.209677419354839	62	62	15	0.241935483870968	0.280701754385965	16	21	3	0	0.304343521411108	1
"934"	"mRNA Splicing"	113	113	1	0.00884955752212389	113	113	27	0.238938053097345	0.350877192982456	20	31	4	0	0.304962884631478	1
"935"	"mRNA Splicing - Major Pathway"	113	113	1	0.00884955752212389	113	113	27	0.238938053097345	0.350877192982456	20	31	4	0	0.304962884631478	1
"907"	"DNA Damage/Telomere Stress Induced Senescence"	58	58	1	0.0172413793103448	58	58	14	0.241379310344828	0.298245614035088	17	18	4	0	0.309641517663782	1
"842"	"Diseases associated with visual transduction"	92	92	3	0.0326086956521739	92	92	22	0.239130434782609	0.350877192982456	20	28	3	0	0.311655542981051	1
"843"	"Visual phototransduction"	92	92	3	0.0326086956521739	92	92	22	0.239130434782609	0.350877192982456	20	28	3	0	0.311655542981051	1
"13"	"G2/M DNA replication checkpoint"	5	5	3	0.6	5	5	1	0.2	0.0175438596491228	1	1	1	0	0.312645923169278	1
"84"	"Activation of caspases through apoptosome-mediated cleavage"	5	5	2	0.4	5	5	1	0.2	0.0175438596491228	1	1	1	0	0.312645923169278	1
"86"	"Cytochrome c-mediated apoptotic response"	5	5	2	0.4	5	5	1	0.2	0.0175438596491228	1	1	1	0	0.312645923169278	1
"365"	"Disinhibition of SNARE formation"	5	5	1	0.2	5	5	1	0.2	0.0526315789473684	3	3	3	0	0.312645923169278	1
"366"	"FGFR1b ligand binding and activation"	5	5	1	0.2	5	5	1	0.2	0.0175438596491228	1	1	1	0	0.312645923169278	1
"369"	"G2 Phase"	5	5	1	0.2	5	5	1	0.2	0.0175438596491228	1	1	1	0	0.312645923169278	1
"375"	"S6K1 signalling"	5	5	1	0.2	5	5	1	0.2	0.0350877192982456	2	2	2	0	0.312645923169278	1
"412"	"CDO in myogenesis"	29	29	5	0.172413793103448	29	29	7	0.241379310344828	0.12280701754386	7	8	2	0	0.316035282882444	1
"414"	"Myogenesis"	29	29	5	0.172413793103448	29	29	7	0.241379310344828	0.12280701754386	7	8	2	0	0.316035282882444	1
"44"	"Frs2-mediated activation"	25	25	12	0.48	25	25	6	0.24	0.12280701754386	7	8	3	0	0.320461663478241	1
"685"	"Lipid digestion, mobilization, and transport"	50	50	4	0.08	50	50	12	0.24	0.210526315789474	12	15	3	0	0.320848393376178	1
"238"	"Toll-Like Receptors Cascades"	144	144	40	0.277777777777778	144	144	34	0.236111111111111	0.385964912280702	22	43	3	0	0.321217914847612	1
"390"	"RIP-mediated NFkB activation via ZBP1"	21	21	4	0.19047619047619	21	21	5	0.238095238095238	0.105263157894737	6	7	2	0	0.32451155006329	1
"480"	"Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)"	21	21	3	0.142857142857143	21	21	5	0.238095238095238	0.12280701754386	7	7	3	0	0.32451155006329	1
"780"	"Inflammasomes"	21	21	1	0.0476190476190476	21	21	5	0.238095238095238	0.105263157894737	6	6	2	0	0.32451155006329	1
"152"	"AKT phosphorylates targets in the nucleus"	9	9	3	0.333333333333333	9	9	2	0.222222222222222	0.0350877192982456	2	2	1	0	0.327001917515612	1
"319"	"S6K1-mediated signalling"	9	9	2	0.222222222222222	9	9	2	0.222222222222222	0.0526315789473684	3	3	2	0	0.327001917515612	1
"589"	"Gamma-carboxylation of protein precursors"	9	9	1	0.111111111111111	9	9	2	0.222222222222222	0.0526315789473684	3	3	2	0	0.327001917515612	1
"405"	"KSRP destabilizes mRNA"	17	17	3	0.176470588235294	17	17	4	0.235294117647059	0.0701754385964912	4	4	1	0	0.327777603906952	1
"54"	"p38MAPK events"	13	13	6	0.461538461538462	13	13	3	0.230769230769231	0.0701754385964912	4	4	2	0	0.329371443292324	1
"307"	"NF-kB is activated and signals survival"	13	13	3	0.230769230769231	13	13	3	0.230769230769231	0.0701754385964912	4	4	2	0	0.329371443292324	1
"455"	"FGFR4 ligand binding and activation"	13	13	2	0.153846153846154	13	13	3	0.230769230769231	0.0526315789473684	3	3	1	0	0.329371443292324	1
"689"	"Caspase-8 activation by cleavage"	13	13	1	0.0769230769230769	13	13	3	0.230769230769231	0.0526315789473684	3	3	1	0	0.329371443292324	1
"696"	"Retrograde neurotrophin signalling"	13	13	1	0.0769230769230769	13	13	3	0.230769230769231	0.0526315789473684	3	3	1	0	0.329371443292324	1
"870"	"Triglyceride Biosynthesis"	42	42	1	0.0238095238095238	42	42	10	0.238095238095238	0.175438596491228	10	11	2	0	0.333000829043115	1
"600"	"Collagen degradation"	38	38	4	0.105263157894737	38	38	9	0.236842105263158	0.175438596491228	10	10	2	0	0.339492964741042	1
"601"	"Cyclin D associated events in G1"	38	38	4	0.105263157894737	38	38	9	0.236842105263158	0.263157894736842	15	15	4	0	0.339492964741042	1
"602"	"G1 Phase"	38	38	4	0.105263157894737	38	38	9	0.236842105263158	0.263157894736842	15	15	4	0	0.339492964741042	1
"469"	"Circadian Clock"	55	55	8	0.145454545454545	55	55	13	0.236363636363636	0.315789473684211	18	24	8	0	0.342303694642819	1
"338"	"Role of LAT2/NTAL/LAB on calcium mobilization"	141	141	30	0.212765957446809	141	141	33	0.234042553191489	0.614035087719298	35	61	15	0	0.343376684148409	1
"323"	"PI3K Cascade"	68	68	15	0.220588235294118	68	68	16	0.235294117647059	0.43859649122807	25	37	15	0	0.347828039246411	1
"809"	"Aquaporin-mediated transport"	51	51	2	0.0392156862745098	51	51	12	0.235294117647059	0.210526315789474	12	14	3	0	0.349274472654494	1
"811"	"SLC-mediated transmembrane transport"	259	259	10	0.0386100386100386	259	259	60	0.231660231660232	0.614035087719298	35	71	2	0	0.350375987453606	1
"52"	"MAPK targets/ Nuclear events mediated by MAP kinases"	30	30	14	0.466666666666667	30	30	7	0.233333333333333	0.140350877192982	8	9	3	0	0.353468856839972	1
"694"	"Ligand-gated ion channel transport"	26	26	2	0.0769230769230769	26	26	6	0.230769230769231	0.087719298245614	5	6	1	0	0.36103127657927	1
"315"	"Signaling by Insulin receptor"	116	116	26	0.224137931034483	116	116	27	0.232758620689655	0.526315789473684	30	50	15	0	0.361128276888522	1
"793"	"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"	22	22	1	0.0454545454545455	22	22	5	0.227272727272727	0.140350877192982	8	8	3	0	0.369034566234129	1
"457"	"Nuclear signaling by ERBB4"	39	39	6	0.153846153846154	39	39	9	0.230769230769231	0.140350877192982	8	10	2	0	0.372753200638987	1
"418"	"Activation of SMO"	18	18	3	0.166666666666667	18	18	4	0.222222222222222	0.105263157894737	6	6	2	0	0.377513983331081	1
"594"	"Synthesis of PIPs at the Golgi membrane"	18	18	2	0.111111111111111	18	18	4	0.222222222222222	0.087719298245614	5	5	2	0	0.377513983331081	1
"748"	"Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha"	18	18	1	0.0555555555555556	18	18	4	0.222222222222222	0.0701754385964912	4	4	1	0	0.377513983331081	1
"217"	"Golgi Cisternae Pericentriolar Stack Reorganization"	14	14	4	0.285714285714286	14	14	3	0.214285714285714	0.087719298245614	5	5	3	0	0.386455582640843	1
"481"	"Removal of the Flap Intermediate"	14	14	2	0.142857142857143	14	14	3	0.214285714285714	0.0526315789473684	3	3	1	0	0.386455582640843	1
"484"	"TRAF3-dependent IRF activation pathway"	14	14	2	0.142857142857143	14	14	3	0.214285714285714	0.228070175438596	13	13	8	0	0.386455582640843	1
"706"	"Regulation of pyruvate dehydrogenase (PDH) complex"	14	14	1	0.0714285714285714	14	14	3	0.214285714285714	0.0526315789473684	3	3	1	0	0.386455582640843	1
"282"	"Apoptosis"	148	148	38	0.256756756756757	148	148	34	0.22972972972973	0.333333333333333	19	44	5	0	0.388956228897188	1
"908"	"Clathrin derived vesicle budding"	61	61	1	0.0163934426229508	61	61	14	0.229508196721311	0.263157894736842	15	19	5	0	0.388981399555701	1
"909"	"trans-Golgi Network Vesicle Budding"	61	61	1	0.0163934426229508	61	61	14	0.229508196721311	0.263157894736842	15	19	5	0	0.388981399555701	1
"844"	"Elongation arrest and recovery"	31	31	1	0.032258064516129	31	31	7	0.225806451612903	0.140350877192982	8	9	3	0	0.391362152248836	1
"845"	"HIV elongation arrest and recovery"	31	31	1	0.032258064516129	31	31	7	0.225806451612903	0.140350877192982	8	9	3	0	0.391362152248836	1
"846"	"Pausing and recovery of HIV elongation"	31	31	1	0.032258064516129	31	31	7	0.225806451612903	0.140350877192982	8	9	3	0	0.391362152248836	1
"847"	"Pausing and recovery of Tat-mediated HIV elongation"	31	31	1	0.032258064516129	31	31	7	0.225806451612903	0.140350877192982	8	9	3	0	0.391362152248836	1
"850"	"Tat-mediated HIV elongation arrest and recovery"	31	31	1	0.032258064516129	31	31	7	0.225806451612903	0.140350877192982	8	9	3	0	0.391362152248836	1
"5"	"Activation of the AP-1 family of transcription factors"	10	10	8	0.8	10	10	2	0.2	0.0701754385964912	4	4	3	0	0.39562980877232	1
"83"	"Activation of PPARGC1A (PGC-1alpha) by phosphorylation"	10	10	4	0.4	10	10	2	0.2	0.0350877192982456	2	2	1	0	0.39562980877232	1
"92"	"Role of DCC in regulating apoptosis"	10	10	4	0.4	10	10	2	0.2	0.0350877192982456	2	2	1	0	0.39562980877232	1
"93"	"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation"	10	10	4	0.4	10	10	2	0.2	0.0350877192982456	2	2	1	0	0.39562980877232	1
"370"	"GP1b-IX-V activation signalling"	10	10	2	0.2	10	10	2	0.2	0.0701754385964912	4	4	2	0	0.39562980877232	1
"637"	"MASTL Facilitates Mitotic Progression"	10	10	1	0.1	10	10	2	0.2	0.0350877192982456	2	2	1	0	0.39562980877232	1
"640"	"Regulated proteolysis of p75NTR"	10	10	1	0.1	10	10	2	0.2	0.0350877192982456	2	2	1	0	0.39562980877232	1
"815"	"Attenuation phase"	27	27	1	0.037037037037037	27	27	6	0.222222222222222	0.245614035087719	14	15	8	0	0.401961508463421	1
"42"	"p75NTR negatively regulates cell cycle via SC1"	6	6	3	0.5	6	6	1	0.166666666666667	0.0175438596491228	1	1	1	0	0.403681973643943	1
"156"	"DNA replication initiation"	6	6	2	0.333333333333333	6	6	1	0.166666666666667	0.0175438596491228	1	1	1	0	0.403681973643943	1
"157"	"FGFR2b ligand binding and activation"	6	6	2	0.333333333333333	6	6	1	0.166666666666667	0.0175438596491228	1	1	1	0	0.403681973643943	1
"163"	"Phosphorylation of Emi1"	6	6	2	0.333333333333333	6	6	1	0.166666666666667	0.0175438596491228	1	1	1	0	0.403681973643943	1
"167"	"Telomere C-strand synthesis initiation"	6	6	2	0.333333333333333	6	6	1	0.166666666666667	0.0175438596491228	1	1	1	0	0.403681973643943	1
"169"	"Uptake and function of diphtheria toxin"	6	6	2	0.333333333333333	6	6	1	0.166666666666667	0.0175438596491228	1	1	1	0	0.403681973643943	1
"426"	"IRS activation"	6	6	1	0.166666666666667	6	6	1	0.166666666666667	0.0175438596491228	1	1	1	0	0.403681973643943	1
"430"	"Presynaptic phase of homologous DNA pairing and strand exchange"	6	6	1	0.166666666666667	6	6	1	0.166666666666667	0.0175438596491228	1	1	1	0	0.403681973643943	1
"432"	"Release of eIF4E"	6	6	1	0.166666666666667	6	6	1	0.166666666666667	0.0175438596491228	1	1	1	0	0.403681973643943	1
"439"	"vRNP Assembly"	6	6	1	0.166666666666667	6	6	1	0.166666666666667	0.0175438596491228	1	1	1	0	0.403681973643943	1
"241"	"Negative regulation of FGFR signaling"	40	40	11	0.275	40	40	9	0.225	0.228070175438596	13	15	5	0	0.406309589322326	1
"866"	"PRC2 methylates histones and DNA"	40	40	1	0.025	40	40	9	0.225	0.175438596491228	10	11	2	0	0.406309589322326	1
"417"	"Cellular Senescence"	158	158	27	0.170886075949367	158	158	36	0.227848101265823	0.508771929824561	29	48	4	0	0.410153159031163	1
"330"	"FGFR ligand binding and activation"	23	23	5	0.217391304347826	23	23	5	0.217391304347826	0.157894736842105	9	9	5	0	0.413749300571592	1
"448"	"Signaling by NODAL"	19	19	3	0.157894736842105	19	19	4	0.210526315789474	0.0701754385964912	4	4	1	0	0.427139300302798	1
"757"	"Synthesis of PC"	19	19	1	0.0526315789473684	19	19	4	0.210526315789474	0.0701754385964912	4	5	2	0	0.427139300302798	1
"408"	"Regulation of PLK1 Activity at G2/M Transition"	80	80	14	0.175	80	80	18	0.225	0.280701754385965	16	24	3	0	0.429313421195841	1
"651"	"DNA strand elongation"	32	32	3	0.09375	32	32	7	0.21875	0.12280701754386	7	7	1	0	0.42934644142628	1
"729"	"TGF-beta receptor signaling activates SMADs"	32	32	2	0.0625	32	32	7	0.21875	0.105263157894737	6	7	1	0	0.42934644142628	1
"852"	"DNA methylation"	32	32	1	0.03125	32	32	7	0.21875	0.140350877192982	8	8	2	0	0.42934644142628	1
"701"	"Interferon alpha/beta signaling"	67	67	5	0.0746268656716418	67	67	15	0.223880597014925	0.228070175438596	13	18	3	0	0.432852416275448	1
"452"	"Anchoring of the basal body to the plasma membrane"	89	89	14	0.157303370786517	89	89	20	0.224719101123595	0.350877192982456	20	26	3	0	0.434579167124719	1
"821"	"Synthesis of PA"	28	28	1	0.0357142857142857	28	28	6	0.214285714285714	0.12280701754386	7	7	2	0	0.442800234042727	1
"153"	"Activation of BAD and translocation to mitochondria"	15	15	5	0.333333333333333	15	15	3	0.2	0.0526315789473684	3	3	1	0	0.442835938395881	1
"379"	"Synthesis of bile acids and bile salts via 27-hydroxycholesterol"	15	15	3	0.2	15	15	3	0.2	0.0526315789473684	3	3	1	0	0.442835938395881	1
"714"	"Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)"	15	15	1	0.0666666666666667	15	15	3	0.2	0.0526315789473684	3	3	1	0	0.442835938395881	1
"716"	"NRIF signals cell death from the nucleus"	15	15	1	0.0666666666666667	15	15	3	0.2	0.0526315789473684	3	3	1	0	0.442835938395881	1
"721"	"WNT5A-dependent internalization of FZD4"	15	15	1	0.0666666666666667	15	15	3	0.2	0.0701754385964912	4	5	3	0	0.442835938395881	1
"275"	"Programmed Cell Death"	160	160	42	0.2625	160	160	36	0.225	0.368421052631579	21	46	5	0	0.444161574623208	1
"671"	"Phospholipid metabolism"	138	138	12	0.0869565217391304	138	138	31	0.22463768115942	0.596491228070175	34	56	15	0	0.445642598983746	1
"924"	"Transport of inorganic cations/anions and amino acids/oligopeptides"	94	94	1	0.0106382978723404	94	94	21	0.223404255319149	0.315789473684211	18	24	2	0	0.4480591032946	1
"867"	"Unfolded Protein Response (UPR)"	81	81	2	0.0246913580246914	81	81	18	0.222222222222222	0.263157894736842	15	20	2	0	0.453251414895909	1
"135"	"Degradation of GLI1 by the proteasome"	59	59	21	0.355932203389831	59	59	13	0.220338983050847	0.210526315789474	12	14	2	0	0.453944178699811	1
"57"	"Purine ribonucleoside monophosphate biosynthesis"	11	11	5	0.454545454545455	11	11	2	0.181818181818182	0.0350877192982456	2	2	1	0	0.462200033954739	1
"247"	"TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling"	11	11	3	0.272727272727273	11	11	2	0.181818181818182	0.0350877192982456	2	2	1	0	0.462200033954739	1
"400"	"Import of palmitoyl-CoA into the mitochondrial matrix"	11	11	2	0.181818181818182	11	11	2	0.181818181818182	0.0526315789473684	3	3	2	0	0.462200033954739	1
"403"	"mTORC1-mediated signalling"	11	11	2	0.181818181818182	11	11	2	0.181818181818182	0.0526315789473684	3	3	2	0	0.462200033954739	1
"653"	"Androgen biosynthesis"	11	11	1	0.0909090909090909	11	11	2	0.181818181818182	0.0350877192982456	2	2	1	0	0.462200033954739	1
"654"	"Base-free sugar-phosphate removal via the single-nucleotide replacement pathway"	11	11	1	0.0909090909090909	11	11	2	0.181818181818182	0.0350877192982456	2	2	1	0	0.462200033954739	1
"244"	"Purine metabolism"	33	33	9	0.272727272727273	33	33	7	0.212121212121212	0.105263157894737	6	7	1	0	0.467076602262919	1
"332"	"Cellular response to heat stress"	51	51	11	0.215686274509804	51	51	11	0.215686274509804	0.333333333333333	19	22	8	0	0.478064932684558	1
"325"	"Oxidative Stress Induced Senescence"	91	91	20	0.21978021978022	91	91	20	0.21978021978022	0.298245614035088	17	25	3	0	0.479992765571122	1
"396"	"Cytochrome P450 - arranged by substrate type"	60	60	11	0.183333333333333	60	60	13	0.216666666666667	0.192982456140351	11	16	2	0	0.481877230279086	1
"361"	"SHC-mediated cascade"	29	29	6	0.206896551724138	29	29	6	0.206896551724138	0.175438596491228	10	10	5	0	0.483134536684635	1
"828"	"PIWI-interacting RNA (piRNA) biogenesis"	29	29	1	0.0344827586206897	29	29	6	0.206896551724138	0.105263157894737	6	7	2	0	0.483134536684635	1
"743"	"Glucose metabolism"	69	69	4	0.0579710144927536	69	69	15	0.217391304347826	0.175438596491228	10	15	1	0	0.485061089307774	1
"605"	"Transport of vitamins, nucleosides, and related molecules"	38	38	4	0.105263157894737	38	38	8	0.210526315789474	0.12280701754386	7	9	2	0	0.487961495707004	1
"8"	"Activation of NIMA Kinases NEK9, NEK6, NEK7"	7	7	5	0.714285714285714	7	7	1	0.142857142857143	0.0175438596491228	1	1	1	0	0.488454743845951	1
"9"	"CREB phosphorylation"	7	7	5	0.714285714285714	7	7	1	0.142857142857143	0.0175438596491228	1	1	1	0	0.488454743845951	1
"213"	"Apoptotic factor-mediated response"	7	7	2	0.285714285714286	7	7	1	0.142857142857143	0.0175438596491228	1	1	1	0	0.488454743845951	1
"476"	"Pentose phosphate pathway (hexose monophosphate shunt)"	7	7	1	0.142857142857143	7	7	1	0.142857142857143	0.0175438596491228	1	1	1	0	0.488454743845951	1
"482"	"Scavenging by Class F Receptors"	7	7	1	0.142857142857143	7	7	1	0.142857142857143	0.0526315789473684	3	3	3	0	0.488454743845951	1
"182"	"p75NTR signals via NF-kB"	16	16	5	0.3125	16	16	3	0.1875	0.0701754385964912	4	4	2	0	0.49752473542061	1
"290"	"Nucleotide-like (purinergic) receptors"	16	16	4	0.25	16	16	3	0.1875	0.0526315789473684	3	3	1	0	0.49752473542061	1
"393"	"Processive synthesis on the lagging strand"	16	16	3	0.1875	16	16	3	0.1875	0.0526315789473684	3	3	1	0	0.49752473542061	1
"727"	"Mismatch Repair"	16	16	1	0.0625	16	16	3	0.1875	0.0526315789473684	3	3	1	0	0.49752473542061	1
"441"	"Cellular responses to stress"	248	248	40	0.161290322580645	248	248	55	0.221774193548387	0.684210526315789	39	76	8	0	0.499201157327836	1
"229"	"Activation of BH3-only proteins"	25	25	7	0.28	25	25	5	0.2	0.087719298245614	5	5	1	0	0.501548798012531	1
"683"	"ADP signalling through P2Y purinoceptor 1"	25	25	2	0.08	25	25	5	0.2	0.12280701754386	7	7	2	0	0.501548798012531	1
"513"	"Gastrin-CREB signalling pathway via PKC and MAPK"	217	217	30	0.138248847926267	217	217	48	0.221198156682028	0.719298245614035	41	75	15	0	0.502609891218427	1
"787"	"Iron uptake and transport"	43	43	2	0.0465116279069767	43	43	9	0.209302325581395	0.12280701754386	7	10	2	0	0.506317193111205	1
"872"	"HIV Transcription Initiation"	43	43	1	0.0232558139534884	43	43	9	0.209302325581395	0.175438596491228	10	11	2	0	0.506317193111205	1
"873"	"Pyruvate metabolism and Citric Acid (TCA) cycle"	43	43	1	0.0232558139534884	43	43	9	0.209302325581395	0.175438596491228	10	10	2	0	0.506317193111205	1
"874"	"RNA Polymerase II HIV Promoter Escape"	43	43	1	0.0232558139534884	43	43	9	0.209302325581395	0.175438596491228	10	11	2	0	0.506317193111205	1
"875"	"RNA Polymerase II Promoter Escape"	43	43	1	0.0232558139534884	43	43	9	0.209302325581395	0.175438596491228	10	11	2	0	0.506317193111205	1
"876"	"RNA Polymerase II Transcription Initiation"	43	43	1	0.0232558139534884	43	43	9	0.209302325581395	0.175438596491228	10	11	2	0	0.506317193111205	1
"877"	"RNA Polymerase II Transcription Initiation And Promoter Clearance"	43	43	1	0.0232558139534884	43	43	9	0.209302325581395	0.175438596491228	10	11	2	0	0.506317193111205	1
"878"	"RNA Polymerase II Transcription Pre-Initiation And Promoter Opening"	43	43	1	0.0232558139534884	43	43	9	0.209302325581395	0.175438596491228	10	11	2	0	0.506317193111205	1
"864"	"Formation of Fibrin Clot (Clotting Cascade)"	39	39	1	0.0256410256410256	39	39	8	0.205128205128205	0.175438596491228	10	10	2	0	0.522523984227409	1
"710"	"Amine compound SLC transporters"	30	30	2	0.0666666666666667	30	30	6	0.2	0.105263157894737	6	6	1	0	0.522598004463446	1
"648"	"Synthesis of Leukotrienes (LT) and Eoxins (EX)"	21	21	2	0.0952380952380952	21	21	4	0.19047619047619	0.087719298245614	5	5	2	0	0.523233047459237	1
"781"	"Mitochondrial tRNA aminoacylation"	21	21	1	0.0476190476190476	21	21	4	0.19047619047619	0.0701754385964912	4	4	1	0	0.523233047459237	1
"4"	"Reversible hydration of carbon dioxide"	12	12	11	0.916666666666667	12	12	2	0.166666666666667	0.0350877192982456	2	2	1	0	0.525336912877749	1
"289"	"NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10"	12	12	3	0.25	12	12	2	0.166666666666667	0.0350877192982456	2	2	1	0	0.525336912877749	1
"420"	"Bile salt and organic anion SLC transporters"	12	12	2	0.166666666666667	12	12	2	0.166666666666667	0.0350877192982456	2	3	2	0	0.525336912877749	1
"421"	"FGFR3 ligand binding and activation"	12	12	2	0.166666666666667	12	12	2	0.166666666666667	0.105263157894737	6	6	5	0	0.525336912877749	1
"422"	"FGFR3c ligand binding and activation"	12	12	2	0.166666666666667	12	12	2	0.166666666666667	0.105263157894737	6	6	5	0	0.525336912877749	1
"433"	"Signaling by FGFR3 mutants"	12	12	2	0.166666666666667	12	12	2	0.166666666666667	0.105263157894737	6	6	5	0	0.525336912877749	1
"434"	"Signaling by activated point mutants of FGFR3"	12	12	2	0.166666666666667	12	12	2	0.166666666666667	0.105263157894737	6	6	5	0	0.525336912877749	1
"676"	"Death Receptor Signalling"	12	12	1	0.0833333333333333	12	12	2	0.166666666666667	0.0350877192982456	2	2	1	0	0.525336912877749	1
"677"	"Miscellaneous substrates"	12	12	1	0.0833333333333333	12	12	2	0.166666666666667	0.0526315789473684	3	3	2	0	0.525336912877749	1
"529"	"Signaling by Wnt"	286	286	36	0.125874125874126	286	286	63	0.22027972027972	0.684210526315789	39	92	8	0	0.529017836074785	1
"849"	"RNA Polymerase II Pre-transcription Events"	62	62	2	0.032258064516129	62	62	13	0.209677419354839	0.228070175438596	13	17	3	0	0.536835157262029	1
"483"	"Separation of Sister Chromatids"	161	161	23	0.142857142857143	161	161	35	0.217391304347826	0.350877192982456	20	38	2	0	0.537288216743908	1
"364"	"Bile acid and bile salt metabolism"	35	35	7	0.2	35	35	7	0.2	0.12280701754386	7	8	2	0	0.540549112550438	1
"691"	"Downregulation of TGF-beta receptor signaling"	26	26	2	0.0769230769230769	26	26	5	0.192307692307692	0.0701754385964912	4	5	1	0	0.54370405444251	1
"404"	"Energy dependent regulation of mTOR by LKB1-AMPK"	17	17	3	0.176470588235294	17	17	3	0.176470588235294	0.0526315789473684	3	4	2	0	0.549754622040197	1
"565"	"Metabolism of porphyrins"	17	17	2	0.117647058823529	17	17	3	0.176470588235294	0.0526315789473684	3	3	1	0	0.549754622040197	1
"569"	"Platelet sensitization by LDL"	17	17	2	0.117647058823529	17	17	3	0.176470588235294	0.105263157894737	6	6	3	0	0.549754622040197	1
"738"	"Gap-filling DNA repair synthesis and ligation in GG-NER"	17	17	1	0.0588235294117647	17	17	3	0.176470588235294	0.0526315789473684	3	3	1	0	0.549754622040197	1
"739"	"Gap-filling DNA repair synthesis and ligation in TC-NER"	17	17	1	0.0588235294117647	17	17	3	0.176470588235294	0.0526315789473684	3	3	1	0	0.549754622040197	1
"893"	"Amino acid and oligopeptide SLC transporters"	49	49	1	0.0204081632653061	49	49	10	0.204081632653061	0.175438596491228	10	11	2	0	0.553229725933112	1
"723"	"Gluconeogenesis"	31	31	2	0.0645161290322581	31	31	6	0.193548387096774	0.087719298245614	5	6	1	0	0.56087512802604	1
"35"	"Neurotransmitter Clearance In The Synaptic Cleft"	8	8	4	0.5	8	8	1	0.125	0.0350877192982456	2	2	2	0	0.565199452651599	1
"40"	"VEGF binds to VEGFR leading to receptor dimerization"	8	8	4	0.5	8	8	1	0.125	0.0175438596491228	1	1	1	0	0.565199452651599	1
"41"	"VEGF ligand-receptor interactions"	8	8	4	0.5	8	8	1	0.125	0.0175438596491228	1	1	1	0	0.565199452651599	1
"111"	"Erythrocytes take up carbon dioxide and release oxygen"	8	8	3	0.375	8	8	1	0.125	0.0175438596491228	1	1	1	0	0.565199452651599	1
"112"	"Erythrocytes take up oxygen and release carbon dioxide"	8	8	3	0.375	8	8	1	0.125	0.0175438596491228	1	1	1	0	0.565199452651599	1
"116"	"O2/CO2 exchange in erythrocytes"	8	8	3	0.375	8	8	1	0.125	0.0175438596491228	1	1	1	0	0.565199452651599	1
"284"	"BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members"	8	8	2	0.25	8	8	1	0.125	0.0175438596491228	1	1	1	0	0.565199452651599	1
"288"	"HuR stabilizes mRNA"	8	8	2	0.25	8	8	1	0.125	0.0526315789473684	3	3	3	0	0.565199452651599	1
"56"	"CTLA4 inhibitory signaling"	22	22	10	0.454545454545455	22	22	4	0.181818181818182	0.0526315789473684	3	4	1	0	0.56858554193721	1
"243"	"Cyclin A/B1 associated events during G2/M transition"	22	22	6	0.272727272727273	22	22	4	0.181818181818182	0.087719298245614	5	5	2	0	0.56858554193721	1
"314"	"Extrinsic Pathway"	22	22	5	0.227272727272727	22	22	4	0.181818181818182	0.0701754385964912	4	4	1	0	0.56858554193721	1
"659"	"Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters"	22	22	2	0.0909090909090909	22	22	4	0.181818181818182	0.12280701754386	7	7	3	0	0.56858554193721	1
"792"	"Intrinsic Pathway"	22	22	1	0.0454545454545455	22	22	4	0.181818181818182	0.087719298245614	5	5	2	0	0.56858554193721	1
"794"	"Pyruvate metabolism"	22	22	1	0.0454545454545455	22	22	4	0.181818181818182	0.0701754385964912	4	4	1	0	0.56858554193721	1
"100"	"GLI3 is processed to GLI3R by the proteasome"	59	59	23	0.389830508474576	59	59	12	0.203389830508475	0.192982456140351	11	12	1	0	0.578581224402976	1
"684"	"Arachidonic acid metabolism"	50	50	4	0.08	50	50	10	0.2	0.210526315789474	12	13	2	0	0.582977232085152	1
"805"	"IRE1alpha activates chaperones"	50	50	2	0.04	50	50	10	0.2	0.175438596491228	10	10	1	0	0.582977232085152	1
"184"	"Signal regulatory protein (SIRP) family interactions"	13	13	4	0.307692307692308	13	13	2	0.153846153846154	0.0350877192982456	2	2	1	0	0.584126553753376	1
"185"	"p75NTR recruits signalling complexes"	13	13	4	0.307692307692308	13	13	2	0.153846153846154	0.0350877192982456	2	2	1	0	0.584126553753376	1
"310"	"Signaling by Activin"	13	13	3	0.230769230769231	13	13	2	0.153846153846154	0.0350877192982456	2	2	1	0	0.584126553753376	1
"460"	"Resolution of AP sites via the single-nucleotide replacement pathway"	13	13	2	0.153846153846154	13	13	2	0.153846153846154	0.0350877192982456	2	2	1	0	0.584126553753376	1
"690"	"DEx/H-box helicases activate type I IFN and inflammatory cytokines production"	13	13	1	0.0769230769230769	13	13	2	0.153846153846154	0.0526315789473684	3	3	2	0	0.584126553753376	1
"697"	"Trafficking and processing of endosomal TLR"	13	13	1	0.0769230769230769	13	13	2	0.153846153846154	0.0526315789473684	3	3	2	0	0.584126553753376	1
"322"	"mTOR signalling"	27	27	6	0.222222222222222	27	27	5	0.185185185185185	0.087719298245614	5	7	2	0	0.58420192472225	1
"702"	"Detoxification of Reactive Oxygen Species"	27	27	2	0.0740740740740741	27	27	5	0.185185185185185	0.087719298245614	5	5	1	0	0.58420192472225	1
"771"	"Condensation of Prophase Chromosomes"	41	41	2	0.0487804878048781	41	41	8	0.195121951219512	0.228070175438596	13	13	4	0	0.588987697996764	1
"171"	"TCR signaling"	64	64	21	0.328125	64	64	13	0.203125	0.473684210526316	27	32	15	0	0.589815611367439	1
"486"	"Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)"	78	78	11	0.141025641025641	78	78	16	0.205128205128205	0.228070175438596	13	19	2	0	0.596254449282532	1
"487"	"Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4)"	78	78	11	0.141025641025641	78	78	16	0.205128205128205	0.228070175438596	13	19	2	0	0.596254449282532	1
"488"	"Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency)"	78	78	11	0.141025641025641	78	78	16	0.205128205128205	0.228070175438596	13	19	2	0	0.596254449282532	1
"489"	"Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5)"	78	78	11	0.141025641025641	78	78	16	0.205128205128205	0.228070175438596	13	19	2	0	0.596254449282532	1
"490"	"Defective CYP19A1 causes Aromatase excess syndrome (AEXS)"	78	78	11	0.141025641025641	78	78	16	0.205128205128205	0.228070175438596	13	19	2	0	0.596254449282532	1
"491"	"Defective CYP1B1 causes Glaucoma"	78	78	11	0.141025641025641	78	78	16	0.205128205128205	0.228070175438596	13	19	2	0	0.596254449282532	1
"492"	"Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)"	78	78	11	0.141025641025641	78	78	16	0.205128205128205	0.228070175438596	13	19	2	0	0.596254449282532	1
"493"	"Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)"	78	78	11	0.141025641025641	78	78	16	0.205128205128205	0.228070175438596	13	19	2	0	0.596254449282532	1
"494"	"Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA)"	78	78	11	0.141025641025641	78	78	16	0.205128205128205	0.228070175438596	13	19	2	0	0.596254449282532	1
"495"	"Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4)"	78	78	11	0.141025641025641	78	78	16	0.205128205128205	0.228070175438596	13	19	2	0	0.596254449282532	1
"496"	"Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX)"	78	78	11	0.141025641025641	78	78	16	0.205128205128205	0.228070175438596	13	19	2	0	0.596254449282532	1
"497"	"Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A)"	78	78	11	0.141025641025641	78	78	16	0.205128205128205	0.228070175438596	13	19	2	0	0.596254449282532	1
"498"	"Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B)"	78	78	11	0.141025641025641	78	78	16	0.205128205128205	0.228070175438596	13	19	2	0	0.596254449282532	1
"499"	"Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)"	78	78	11	0.141025641025641	78	78	16	0.205128205128205	0.228070175438596	13	19	2	0	0.596254449282532	1
"500"	"Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)"	78	78	11	0.141025641025641	78	78	16	0.205128205128205	0.228070175438596	13	19	2	0	0.596254449282532	1
"501"	"Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)"	78	78	11	0.141025641025641	78	78	16	0.205128205128205	0.228070175438596	13	19	2	0	0.596254449282532	1
"502"	"Defective FMO3 causes Trimethylaminuria (TMAU)"	78	78	11	0.141025641025641	78	78	16	0.205128205128205	0.228070175438596	13	19	2	0	0.596254449282532	1
"503"	"Defective MAOA causes Brunner syndrome (BRUNS)"	78	78	11	0.141025641025641	78	78	16	0.205128205128205	0.228070175438596	13	19	2	0	0.596254449282532	1
"504"	"Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD)"	78	78	11	0.141025641025641	78	78	16	0.205128205128205	0.228070175438596	13	19	2	0	0.596254449282532	1
"505"	"Phase 1 - Functionalization of compounds"	78	78	11	0.141025641025641	78	78	16	0.205128205128205	0.228070175438596	13	19	2	0	0.596254449282532	1
"540"	"Regulation of beta-cell development"	32	32	4	0.125	32	32	6	0.1875	0.140350877192982	8	9	4	0	0.597703160273972	1
"547"	"Thrombin signalling through proteinase activated receptors (PARs)"	32	32	4	0.125	32	32	6	0.1875	0.140350877192982	8	9	3	0	0.597703160273972	1
"728"	"Sphingolipid de novo biosynthesis"	32	32	2	0.0625	32	32	6	0.1875	0.105263157894737	6	7	2	0	0.597703160273972	1
"730"	"TRAF6 mediated IRF7 activation"	32	32	2	0.0625	32	32	6	0.1875	0.210526315789474	12	14	8	0	0.597703160273972	1
"764"	"Gene Expression"	1164	1164	59	0.0506872852233677	1164	1164	257	0.220790378006873	0.929824561403509	53	323	5	0	0.598761562431491	1
"588"	"Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon"	18	18	2	0.111111111111111	18	18	3	0.166666666666667	0.087719298245614	5	5	3	0	0.598966233099944	1
"173"	"Downstream TCR signaling"	46	46	15	0.326086956521739	46	46	9	0.195652173913043	0.421052631578947	24	28	15	0	0.600920051112484	1
"758"	"DNA Repair"	115	115	6	0.0521739130434783	115	115	24	0.208695652173913	0.315789473684211	18	27	2	0	0.6053763893728	1
"818"	"Peptide hormone metabolism"	83	83	3	0.036144578313253	83	83	17	0.204819277108434	0.210526315789474	12	23	3	0	0.605846609416754	1
"751"	"Activation of ATR in response to replication stress"	37	37	2	0.0540540540540541	37	37	7	0.189189189189189	0.12280701754386	7	7	1	0	0.609691183072688	1
"527"	"Telomere C-strand (Lagging Strand) Synthesis"	23	23	3	0.130434782608696	23	23	4	0.173913043478261	0.0701754385964912	4	4	1	0	0.611595608983215	1
"798"	"APC-Cdc20 mediated degradation of Nek2A"	23	23	1	0.0434782608695652	23	23	4	0.173913043478261	0.0526315789473684	3	4	1	0	0.611595608983215	1
"855"	"Transcription of the HIV genome"	65	65	2	0.0307692307692308	65	65	13	0.2	0.228070175438596	13	17	3	0	0.61531582265204	1
"774"	"Formation of HIV elongation complex in the absence of HIV Tat"	42	42	2	0.0476190476190476	42	42	8	0.19047619047619	0.157894736842105	9	10	3	0	0.620533149848427	1
"775"	"Formation of HIV-1 elongation complex containing HIV-1 Tat"	42	42	2	0.0476190476190476	42	42	8	0.19047619047619	0.157894736842105	9	10	3	0	0.620533149848427	1
"776"	"Formation of RNA Pol II elongation complex"	42	42	2	0.0476190476190476	42	42	8	0.19047619047619	0.157894736842105	9	10	3	0	0.620533149848427	1
"779"	"HIV Transcription Elongation"	42	42	2	0.0476190476190476	42	42	8	0.19047619047619	0.157894736842105	9	10	3	0	0.620533149848427	1
"783"	"RNA Polymerase II Transcription Elongation"	42	42	2	0.0476190476190476	42	42	8	0.19047619047619	0.157894736842105	9	10	3	0	0.620533149848427	1
"784"	"Tat-mediated elongation of the HIV-1 transcript"	42	42	2	0.0476190476190476	42	42	8	0.19047619047619	0.157894736842105	9	10	3	0	0.620533149848427	1
"335"	"PKB-mediated events"	28	28	6	0.214285714285714	28	28	5	0.178571428571429	0.087719298245614	5	7	2	0	0.622766022180302	1
"819"	"Dual incision reaction in TC-NER"	28	28	1	0.0357142857142857	28	28	5	0.178571428571429	0.0701754385964912	4	5	1	0	0.622766022180302	1
"820"	"Formation of transcription-coupled NER (TC-NER) repair complex"	28	28	1	0.0357142857142857	28	28	5	0.178571428571429	0.0701754385964912	4	5	1	0	0.622766022180302	1
"959"	"Diseases of glycosylation"	226	226	1	0.00442477876106195	226	226	48	0.212389380530973	0.526315789473684	30	54	3	0	0.631029640448491	1
"339"	"E2F mediated regulation of DNA replication"	33	33	7	0.212121212121212	33	33	6	0.181818181818182	0.157894736842105	9	9	4	0	0.632871848969255	1
"858"	"Sialic acid metabolism"	33	33	1	0.0303030303030303	33	33	6	0.181818181818182	0.087719298245614	5	6	1	0	0.632871848969255	1
"60"	"G2/M DNA damage checkpoint"	9	9	4	0.444444444444444	9	9	1	0.111111111111111	0.0175438596491228	1	1	1	0	0.633255891261881	1
"63"	"Pyrimidine salvage reactions"	9	9	4	0.444444444444444	9	9	1	0.111111111111111	0.0175438596491228	1	1	1	0	0.633255891261881	1
"317"	"Formyl peptide receptors bind formyl peptides and many other ligands"	9	9	2	0.222222222222222	9	9	1	0.111111111111111	0.0175438596491228	1	1	1	0	0.633255891261881	1
"336"	"Regulation of AMPK activity via LKB1"	14	14	3	0.214285714285714	14	14	2	0.142857142857143	0.0526315789473684	3	3	2	0	0.638036818602249	1
"471"	"FGFR1 ligand binding and activation"	14	14	2	0.142857142857143	14	14	2	0.142857142857143	0.0350877192982456	2	2	1	0	0.638036818602249	1
"475"	"Leading Strand Synthesis"	14	14	2	0.142857142857143	14	14	2	0.142857142857143	0.0350877192982456	2	2	1	0	0.638036818602249	1
"477"	"Polymerase switching"	14	14	2	0.142857142857143	14	14	2	0.142857142857143	0.0350877192982456	2	2	1	0	0.638036818602249	1
"478"	"Polymerase switching on the C-strand of the telomere"	14	14	2	0.142857142857143	14	14	2	0.142857142857143	0.0350877192982456	2	2	1	0	0.638036818602249	1
"508"	"Mitotic Anaphase"	172	172	24	0.13953488372093	172	172	36	0.209302325581395	0.350877192982456	20	39	2	0	0.64192585167565	1
"603"	"Na+/Cl- dependent neurotransmitter transporters"	19	19	2	0.105263157894737	19	19	3	0.157894736842105	0.0526315789473684	3	3	1	0	0.644786748512517	1
"248"	"Hedgehog 'on' state"	85	85	23	0.270588235294118	85	85	17	0.2	0.263157894736842	15	21	2	0	0.649658317598615	1
"436"	"Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"	24	24	4	0.166666666666667	24	24	4	0.166666666666667	0.0701754385964912	4	4	1	0	0.651992378261877	1
"586"	"FCERI mediated Ca+2 mobilization"	62	62	7	0.112903225806452	62	62	12	0.193548387096774	0.210526315789474	12	17	3	0	0.6563238552443	1
"512"	"Mitotic Metaphase and Anaphase"	173	173	24	0.138728323699422	173	173	36	0.208092485549133	0.350877192982456	20	39	2	0	0.657050667058741	1
"892"	"XBP1(S) activates chaperone genes"	48	48	1	0.0208333333333333	48	48	9	0.1875	0.157894736842105	9	9	1	0	0.658827301853231	1
"208"	"Regulation of mRNA stability by proteins that bind AU-rich elements"	86	86	25	0.290697674418605	86	86	17	0.197674418604651	0.263157894736842	15	21	3	0	0.670606333491455	1
"826"	"RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription"	114	114	4	0.0350877192982456	114	114	23	0.201754385964912	0.280701754385965	16	29	3	0	0.672427350383088	1
"830"	"formation of the beta-catenin:TCF transactivating complex"	58	58	2	0.0344827586206897	58	58	11	0.189655172413793	0.421052631578947	24	27	8	0	0.673599834188957	1
"519"	"G2/M Checkpoints"	44	44	6	0.136363636363636	44	44	8	0.181818181818182	0.140350877192982	8	8	1	0	0.679584364908495	1
"521"	"Depolymerisation of the Nuclear Lamina"	15	15	2	0.133333333333333	15	15	2	0.133333333333333	0.0701754385964912	4	4	3	0	0.686837038653841	1
"715"	"Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)"	15	15	1	0.0666666666666667	15	15	2	0.133333333333333	0.0350877192982456	2	2	1	0	0.686837038653841	1
"374"	"Regulation of gene expression in beta cells"	20	20	4	0.2	20	20	3	0.15	0.0526315789473684	3	3	1	0	0.687003834335119	1
"378"	"Signaling by Hippo"	20	20	4	0.2	20	20	3	0.15	0.0526315789473684	3	3	1	0	0.687003834335119	1
"630"	"Cobalamin (Cbl, vitamin B12) transport and metabolism"	20	20	2	0.1	20	20	3	0.15	0.0701754385964912	4	4	2	0	0.687003834335119	1
"725"	"G alpha (q) signalling events"	189	189	12	0.0634920634920635	189	189	39	0.206349206349206	0.596491228070175	34	61	15	0	0.688654439191223	1
"445"	"Regulation of IFNA signaling"	25	25	4	0.16	25	25	4	0.16	0.087719298245614	5	5	2	0	0.689603273324213	1
"868"	"Transcription"	203	203	5	0.0246305418719212	203	203	42	0.206896551724138	0.43859649122807	25	53	3	0	0.691030586959048	1
"747"	"Meiotic recombination"	54	54	3	0.0555555555555556	54	54	10	0.185185185185185	0.175438596491228	10	11	2	0	0.691991369237951	1
"88"	"IRAK1 recruits IKK complex"	10	10	4	0.4	10	10	1	0.1	0.0175438596491228	1	1	1	0	0.692662411884271	1
"89"	"IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation"	10	10	4	0.4	10	10	1	0.1	0.0175438596491228	1	1	1	0	0.692662411884271	1
"194"	"Regulation of signaling by NODAL"	10	10	3	0.3	10	10	1	0.1	0.0175438596491228	1	1	1	0	0.692662411884271	1
"371"	"Nef Mediated CD4 Down-regulation"	10	10	2	0.2	10	10	1	0.1	0.0175438596491228	1	1	1	0	0.692662411884271	1
"632"	"E2F-enabled inhibition of pre-replication complex formation"	10	10	1	0.1	10	10	1	0.1	0.0175438596491228	1	1	1	0	0.692662411884271	1
"638"	"Methylation"	10	10	1	0.1	10	10	1	0.1	0.0350877192982456	2	2	2	0	0.692662411884271	1
"189"	"Costimulation by the CD28 family"	73	73	22	0.301369863013699	73	73	14	0.191780821917808	0.403508771929825	23	30	15	0	0.693159829518389	1
"629"	"Activation of the pre-replicative complex"	30	30	3	0.1	30	30	5	0.166666666666667	0.0701754385964912	4	5	1	0	0.693340032749408	1
"835"	"Gap junction trafficking and regulation"	30	30	1	0.0333333333333333	30	30	5	0.166666666666667	0.087719298245614	5	5	1	0	0.693340032749408	1
"99"	"Degradation of GLI2 by the proteasome"	59	59	23	0.389830508474576	59	59	11	0.186440677966102	0.175438596491228	10	11	1	0	0.697859904772612	1
"763"	"G alpha (i) signalling events"	236	236	12	0.0508474576271186	236	236	49	0.207627118644068	0.508771929824561	29	56	3	0	0.700811105882247	1
"761"	"Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds"	97	97	5	0.0515463917525773	97	97	19	0.195876288659794	0.315789473684211	18	25	2	0	0.702670532967576	1
"797"	"Transcription-coupled NER (TC-NER)"	45	45	2	0.0444444444444444	45	45	8	0.177777777777778	0.12280701754386	7	8	1	0	0.706909218814651	1
"395"	"Host Interactions of HIV factors"	135	135	25	0.185185185185185	135	135	27	0.2	0.333333333333333	19	32	3	0	0.712343761827679	1
"812"	"Insulin receptor recycling"	26	26	1	0.0384615384615385	26	26	4	0.153846153846154	0.0526315789473684	3	4	1	0	0.724341182581761	1
"813"	"RNA Pol II CTD phosphorylation and interaction with CE"	26	26	1	0.0384615384615385	26	26	4	0.153846153846154	0.0701754385964912	4	4	1	0	0.724341182581761	1
"644"	"disassembly of the destruction complex and recruitment of AXIN to the membrane"	31	31	3	0.0967741935483871	31	31	5	0.161290322580645	0.140350877192982	8	8	3	0	0.725131609883016	1
"474"	"Lagging Strand Synthesis"	21	21	3	0.142857142857143	21	21	3	0.142857142857143	0.0526315789473684	3	3	1	0	0.725538137129444	1
"645"	"Aflatoxin activation and detoxification"	21	21	2	0.0952380952380952	21	21	3	0.142857142857143	0.0526315789473684	3	3	1	0	0.725538137129444	1
"646"	"Defective ACY1 causes encephalopathy"	21	21	2	0.0952380952380952	21	21	3	0.142857142857143	0.0526315789473684	3	3	1	0	0.725538137129444	1
"773"	"APC/C:Cdc20 mediated degradation of Cyclin B"	21	21	1	0.0476190476190476	21	21	3	0.142857142857143	0.0526315789473684	3	3	1	0	0.725538137129444	1
"468"	"Signaling by Retinoic Acid"	41	41	6	0.146341463414634	41	41	7	0.170731707317073	0.12280701754386	7	7	1	0	0.729663361659587	1
"446"	"Senescence-Associated Secretory Phenotype (SASP)"	75	75	12	0.16	75	75	14	0.186666666666667	0.298245614035088	17	18	3	0	0.734482860279368	1
"141"	"Nuclear Receptor transcription pathway"	51	51	18	0.352941176470588	51	51	9	0.176470588235294	0.12280701754386	7	9	1	0	0.735978386868923	1
"664"	"Assembly of the primary cilium"	179	179	16	0.0893854748603352	179	179	36	0.201117318435754	0.43859649122807	25	49	4	0	0.740783617458678	1
"901"	"RNA Polymerase II Transcription"	104	104	2	0.0192307692307692	104	104	20	0.192307692307692	0.280701754385965	16	25	3	0	0.742764662254419	1
"397"	"CYP2E1 reactions"	11	11	2	0.181818181818182	11	11	1	0.0909090909090909	0.0175438596491228	1	1	1	0	0.743876273646389	1
"398"	"FGFR1c ligand binding and activation"	11	11	2	0.181818181818182	11	11	1	0.0909090909090909	0.0175438596491228	1	1	1	0	0.743876273646389	1
"399"	"Hormone ligand-binding receptors"	11	11	2	0.181818181818182	11	11	1	0.0909090909090909	0.0175438596491228	1	1	1	0	0.743876273646389	1
"402"	"Signaling by activated point mutants of FGFR1"	11	11	2	0.181818181818182	11	11	1	0.0909090909090909	0.0175438596491228	1	1	1	0	0.743876273646389	1
"662"	"Tryptophan catabolism"	11	11	1	0.0909090909090909	11	11	1	0.0909090909090909	0.0175438596491228	1	1	1	0	0.743876273646389	1
"652"	"Signal amplification"	32	32	3	0.09375	32	32	5	0.15625	0.12280701754386	7	7	2	0	0.75453817517741	1
"853"	"Formation of the Early Elongation Complex"	32	32	1	0.03125	32	32	5	0.15625	0.087719298245614	5	5	1	0	0.75453817517741	1
"854"	"Formation of the HIV-1 Early Elongation Complex"	32	32	1	0.03125	32	32	5	0.15625	0.087719298245614	5	5	1	0	0.75453817517741	1
"466"	"Synthesis of bile acids and bile salts"	27	27	4	0.148148148148148	27	27	4	0.148148148148148	0.0701754385964912	4	4	1	0	0.756191013913468	1
"329"	"S Phase"	124	124	27	0.217741935483871	124	124	24	0.193548387096774	0.333333333333333	19	28	4	0	0.759249909995526	1
"516"	"Cholesterol biosynthesis"	22	22	3	0.136363636363636	22	22	3	0.136363636363636	0.0701754385964912	4	4	2	0	0.760416491616608	1
"517"	"Early Phase of HIV Life Cycle"	22	22	3	0.136363636363636	22	22	3	0.136363636363636	0.0701754385964912	4	4	2	0	0.760416491616608	1
"790"	"ADP signalling through P2Y purinoceptor 12"	22	22	1	0.0454545454545455	22	22	3	0.136363636363636	0.0526315789473684	3	3	1	0	0.760416491616608	1
"140"	"G1/S-Specific Transcription"	17	17	6	0.352941176470588	17	17	2	0.117647058823529	0.0350877192982456	2	2	1	0	0.769260894218824	1
"559"	"Activated point mutants of FGFR2"	17	17	2	0.117647058823529	17	17	2	0.117647058823529	0.0350877192982456	2	2	1	0	0.769260894218824	1
"560"	"Beta-catenin phosphorylation cascade"	17	17	2	0.117647058823529	17	17	2	0.117647058823529	0.0350877192982456	2	2	1	0	0.769260894218824	1
"562"	"FGFR2 ligand binding and activation"	17	17	2	0.117647058823529	17	17	2	0.117647058823529	0.0350877192982456	2	2	1	0	0.769260894218824	1
"570"	"Signaling by FGFR2 mutants"	17	17	2	0.117647058823529	17	17	2	0.117647058823529	0.0350877192982456	2	2	1	0	0.769260894218824	1
"741"	"Synthesis, secretion, and deacylation of Ghrelin"	17	17	1	0.0588235294117647	17	17	2	0.117647058823529	0.0526315789473684	3	3	2	0	0.769260894218824	1
"606"	"Defective AMN causes hereditary megaloblastic anemia 1"	87	87	9	0.103448275862069	87	87	16	0.183908045977011	0.280701754385965	16	18	2	0	0.777872559054627	1
"607"	"Defective BTD causes biotidinase deficiency"	87	87	9	0.103448275862069	87	87	16	0.183908045977011	0.280701754385965	16	18	2	0	0.777872559054627	1
"608"	"Defective CD320 causes methylmalonic aciduria"	87	87	9	0.103448275862069	87	87	16	0.183908045977011	0.280701754385965	16	18	2	0	0.777872559054627	1
"609"	"Defective CUBN causes hereditary megaloblastic anemia 1"	87	87	9	0.103448275862069	87	87	16	0.183908045977011	0.280701754385965	16	18	2	0	0.777872559054627	1
"610"	"Defective GIF causes intrinsic factor deficiency"	87	87	9	0.103448275862069	87	87	16	0.183908045977011	0.280701754385965	16	18	2	0	0.777872559054627	1
"611"	"Defective HLCS causes multiple carboxylase deficiency"	87	87	9	0.103448275862069	87	87	16	0.183908045977011	0.280701754385965	16	18	2	0	0.777872559054627	1
"612"	"Defective LMBRD1 causes methylmalonic aciduria and homocystinuria type cblF"	87	87	9	0.103448275862069	87	87	16	0.183908045977011	0.280701754385965	16	18	2	0	0.777872559054627	1
"613"	"Defective MMAA causes methylmalonic aciduria type cblA"	87	87	9	0.103448275862069	87	87	16	0.183908045977011	0.280701754385965	16	18	2	0	0.777872559054627	1
"614"	"Defective MMAB causes methylmalonic aciduria type cblB"	87	87	9	0.103448275862069	87	87	16	0.183908045977011	0.280701754385965	16	18	2	0	0.777872559054627	1
"615"	"Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC"	87	87	9	0.103448275862069	87	87	16	0.183908045977011	0.280701754385965	16	18	2	0	0.777872559054627	1
"616"	"Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD"	87	87	9	0.103448275862069	87	87	16	0.183908045977011	0.280701754385965	16	18	2	0	0.777872559054627	1
"617"	"Defective MTR causes methylmalonic aciduria and homocystinuria type cblG"	87	87	9	0.103448275862069	87	87	16	0.183908045977011	0.280701754385965	16	18	2	0	0.777872559054627	1
"618"	"Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE"	87	87	9	0.103448275862069	87	87	16	0.183908045977011	0.280701754385965	16	18	2	0	0.777872559054627	1
"619"	"Defective MUT causes methylmalonic aciduria mut type"	87	87	9	0.103448275862069	87	87	16	0.183908045977011	0.280701754385965	16	18	2	0	0.777872559054627	1
"620"	"Defective TCN2 causes hereditary megaloblastic anemia"	87	87	9	0.103448275862069	87	87	16	0.183908045977011	0.280701754385965	16	18	2	0	0.777872559054627	1
"621"	"Defects in biotin (Btn) metabolism"	87	87	9	0.103448275862069	87	87	16	0.183908045977011	0.280701754385965	16	18	2	0	0.777872559054627	1
"622"	"Defects in cobalamin (B12) metabolism"	87	87	9	0.103448275862069	87	87	16	0.183908045977011	0.280701754385965	16	18	2	0	0.777872559054627	1
"623"	"Defects in vitamin and cofactor metabolism"	87	87	9	0.103448275862069	87	87	16	0.183908045977011	0.280701754385965	16	18	2	0	0.777872559054627	1
"624"	"Metabolism of vitamins and cofactors"	87	87	9	0.103448275862069	87	87	16	0.183908045977011	0.280701754385965	16	18	2	0	0.777872559054627	1
"625"	"Metabolism of water-soluble vitamins and cofactors"	87	87	9	0.103448275862069	87	87	16	0.183908045977011	0.280701754385965	16	18	2	0	0.777872559054627	1
"300"	"Intrinsic Pathway for Apoptosis"	38	38	9	0.236842105263158	38	38	6	0.157894736842105	0.105263157894737	6	6	1	0	0.77979777417077	1
"627"	"Signal Transduction"	2062	2062	209	0.101357904946654	2062	2062	449	0.217749757516974	0.982456140350877	56	592	15	0	0.781055547346633	1
"822"	"mRNA Capping"	28	28	1	0.0357142857142857	28	28	4	0.142857142857143	0.0701754385964912	4	4	1	0	0.785196446898938	1
"808"	"G alpha (s) signalling events"	126	126	5	0.0396825396825397	126	126	24	0.19047619047619	0.491228070175439	28	33	3	0	0.787491972359667	1
"15"	"Serotonin receptors"	12	12	7	0.583333333333333	12	12	1	0.0833333333333333	0.0175438596491228	1	1	1	0	0.787584145800117	1
"679"	"Vitamin B5 (pantothenate) metabolism"	12	12	1	0.0833333333333333	12	12	1	0.0833333333333333	0.0175438596491228	1	1	1	0	0.787584145800117	1
"461"	"Transcriptional regulation of white adipocyte differentiation"	78	78	12	0.153846153846154	78	78	14	0.179487179487179	0.333333333333333	19	26	8	0	0.78943982463581	1
"799"	"BBSome-mediated cargo-targeting to cilium"	23	23	1	0.0434782608695652	23	23	3	0.130434782608696	0.0526315789473684	3	3	1	0	0.791747203749954	1
"831"	"HIV Life Cycle"	146	146	5	0.0342465753424658	146	146	28	0.191780821917808	0.315789473684211	18	34	3	0	0.799527944135508	1
"860"	"MHC class II antigen presentation"	103	103	3	0.029126213592233	103	103	19	0.184466019417476	0.280701754385965	16	24	3	0	0.801248406820231	1
"740"	"Global Genomic NER (GG-NER)"	34	34	2	0.0588235294117647	34	34	5	0.147058823529412	0.087719298245614	5	5	1	0	0.806293779913584	1
"801"	"Epigenetic regulation of gene expression"	94	94	4	0.0425531914893617	94	94	17	0.180851063829787	0.315789473684211	18	21	2	0	0.811230753220285	1
"514"	"Extension of Telomeres"	29	29	4	0.137931034482759	29	29	4	0.137931034482759	0.0701754385964912	4	4	1	0	0.811447451025339	1
"910"	"Late Phase of HIV Life Cycle"	133	133	2	0.0150375939849624	133	133	25	0.18796992481203	0.298245614035088	17	30	3	0	0.81580840930067	1
"719"	"Telomere Maintenance"	60	60	4	0.0666666666666667	60	60	10	0.166666666666667	0.157894736842105	9	10	1	0	0.818907311419733	1
"136"	"Cyclin E associated events during G1/S transition"	65	65	23	0.353846153846154	65	65	11	0.169230769230769	0.228070175438596	13	15	4	0	0.81905063341389	1
"218"	"Orc1 removal from chromatin"	70	70	20	0.285714285714286	70	70	12	0.171428571428571	0.245614035087719	14	15	4	0	0.819549845822856	1
"221"	"Switching of origins to a post-replicative state"	70	70	20	0.285714285714286	70	70	12	0.171428571428571	0.245614035087719	14	15	4	0	0.819549845822856	1
"352"	"Pyrimidine metabolism"	24	24	5	0.208333333333333	24	24	3	0.125	0.0350877192982456	2	3	1	0	0.819698168847569	1
"424"	"IKK complex recruitment mediated by RIP1"	24	24	4	0.166666666666667	24	24	3	0.125	0.0350877192982456	2	3	1	0	0.819698168847569	1
"437"	"TRAF6 mediated NF-kB activation"	24	24	4	0.166666666666667	24	24	3	0.125	0.087719298245614	5	5	2	0	0.819698168847569	1
"803"	"Cytosolic tRNA aminoacylation"	24	24	1	0.0416666666666667	24	24	3	0.125	0.0701754385964912	4	4	2	0	0.819698168847569	1
"91"	"Regulation of Apoptosis"	50	50	20	0.4	50	50	8	0.16	0.12280701754386	7	8	1	0	0.820127687971827	1
"806"	"Nucleotide Excision Repair"	50	50	2	0.04	50	50	8	0.16	0.12280701754386	7	8	1	0	0.820127687971827	1
"21"	"AKT phosphorylates targets in the cytosol"	13	13	7	0.538461538461538	13	13	1	0.0769230769230769	0.0175438596491228	1	1	1	0	0.824576435263161	1
"309"	"Purine salvage"	13	13	3	0.230769230769231	13	13	1	0.0769230769230769	0.0175438596491228	1	1	1	0	0.824576435263161	1
"454"	"FGFR2c ligand binding and activation"	13	13	2	0.153846153846154	13	13	1	0.0769230769230769	0.0175438596491228	1	1	1	0	0.824576435263161	1
"693"	"Initiation of Nuclear Envelope Reformation"	13	13	1	0.0769230769230769	13	13	1	0.0769230769230769	0.0175438596491228	1	1	1	0	0.824576435263161	1
"695"	"Nuclear Envelope Reassembly"	13	13	1	0.0769230769230769	13	13	1	0.0769230769230769	0.0175438596491228	1	1	1	0	0.824576435263161	1
"755"	"Glucuronidation"	19	19	1	0.0526315789473684	19	19	2	0.105263157894737	0.0350877192982456	2	2	1	0	0.833044778554491	1
"713"	"HSF1 activation"	30	30	2	0.0666666666666667	30	30	4	0.133333333333333	0.087719298245614	5	5	2	0	0.835068934680526	1
"836"	"Glucagon-type ligand receptors"	30	30	1	0.0333333333333333	30	30	4	0.133333333333333	0.0701754385964912	4	4	1	0	0.835068934680526	1
"839"	"RNA Polymerase I Promoter Opening"	30	30	1	0.0333333333333333	30	30	4	0.133333333333333	0.0701754385964912	4	4	1	0	0.835068934680526	1
"840"	"Tight junction interactions"	30	30	1	0.0333333333333333	30	30	4	0.133333333333333	0.087719298245614	5	5	2	0	0.835068934680526	1
"295"	"Antigen processing-Cross presentation"	81	81	20	0.246913580246914	81	81	14	0.172839506172839	0.263157894736842	15	17	3	0	0.835876844155872	1
"134"	"SCF(Skp2)-mediated degradation of p27/p21"	56	56	20	0.357142857142857	56	56	9	0.160714285714286	0.140350877192982	8	10	2	0	0.836567427385806	1
"150"	"degradation of DVL"	56	56	19	0.339285714285714	56	56	9	0.160714285714286	0.175438596491228	10	10	2	0	0.836567427385806	1
"897"	"Cargo trafficking to the periciliary membrane"	51	51	1	0.0196078431372549	51	51	8	0.156862745098039	0.175438596491228	10	13	4	0	0.838159681065307	1
"272"	"Mitotic G1-G1/S phases"	135	135	36	0.266666666666667	135	135	25	0.185185185185185	0.368421052631579	21	31	4	0	0.838813457882438	1
"195"	"FCERI mediated MAPK activation"	77	77	23	0.298701298701299	77	77	13	0.168831168831169	0.175438596491228	10	15	3	0	0.849427317938751	1
"236"	"Removal of licensing factors from origins"	72	72	20	0.277777777777778	72	72	12	0.166666666666667	0.245614035087719	14	15	4	0	0.84961986150514	1
"299"	"Synthesis of DNA"	97	97	23	0.237113402061856	97	97	17	0.175257731958763	0.298245614035088	17	20	4	0	0.851005597659021	1
"442"	"Role of phospholipids in phagocytosis"	62	62	10	0.161290322580645	62	62	10	0.161290322580645	0.368421052631579	21	27	15	0	0.851112632904287	1
"902"	"Synthesis of substrates in N-glycan biosythesis"	52	52	1	0.0192307692307692	52	52	8	0.153846153846154	0.12280701754386	7	8	1	0	0.854747134146318	1
"707"	"Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"	14	14	1	0.0714285714285714	14	14	1	0.0714285714285714	0.0175438596491228	1	1	1	0	0.855666371373313	1
"708"	"repression of WNT target genes"	14	14	1	0.0714285714285714	14	14	1	0.0714285714285714	0.0175438596491228	1	1	1	0	0.855666371373313	1
"724"	"RNA Polymerase I Transcription Initiation"	47	47	3	0.0638297872340425	47	47	7	0.148936170212766	0.12280701754386	7	8	2	0	0.857748029818289	1
"367"	"Formation of tubulin folding intermediates by CCT/TriC"	20	20	4	0.2	20	20	2	0.1	0.0350877192982456	2	2	1	0	0.858816709887321	1
"767"	"Dual incision reaction in GG-NER"	20	20	1	0.05	20	20	2	0.1	0.0350877192982456	2	2	1	0	0.858816709887321	1
"769"	"Formation of incision complex in GG-NER"	20	20	1	0.05	20	20	2	0.1	0.0350877192982456	2	2	1	0	0.858816709887321	1
"871"	"tRNA Aminoacylation"	42	42	1	0.0238095238095238	42	42	6	0.142857142857143	0.12280701754386	7	7	2	0	0.861857513023362	1
"936"	"Asparagine N-linked glycosylation"	118	118	1	0.00847457627118644	118	118	21	0.177966101694915	0.298245614035088	17	24	3	0	0.865381420041784	1
"937"	"Defective ALG1 causes ALG1-CDG (CDG-1k)"	118	118	1	0.00847457627118644	118	118	21	0.177966101694915	0.298245614035088	17	24	3	0	0.865381420041784	1
"938"	"Defective ALG11 causes ALG11-CDG (CDG-1p)"	118	118	1	0.00847457627118644	118	118	21	0.177966101694915	0.298245614035088	17	24	3	0	0.865381420041784	1
"939"	"Defective ALG12 causes ALG12-CDG (CDG-1g)"	118	118	1	0.00847457627118644	118	118	21	0.177966101694915	0.298245614035088	17	24	3	0	0.865381420041784	1
"940"	"Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)"	118	118	1	0.00847457627118644	118	118	21	0.177966101694915	0.298245614035088	17	24	3	0	0.865381420041784	1
"941"	"Defective ALG2 causes ALG2-CDG (CDG-1i)"	118	118	1	0.00847457627118644	118	118	21	0.177966101694915	0.298245614035088	17	24	3	0	0.865381420041784	1
"942"	"Defective ALG3 causes ALG3-CDG (CDG-1d)"	118	118	1	0.00847457627118644	118	118	21	0.177966101694915	0.298245614035088	17	24	3	0	0.865381420041784	1
"943"	"Defective ALG6 causes ALG6-CDG (CDG-1c)"	118	118	1	0.00847457627118644	118	118	21	0.177966101694915	0.298245614035088	17	24	3	0	0.865381420041784	1
"944"	"Defective ALG8 causes ALG8-CDG (CDG-1h)"	118	118	1	0.00847457627118644	118	118	21	0.177966101694915	0.298245614035088	17	24	3	0	0.865381420041784	1
"945"	"Defective ALG9 causes ALG9-CDG (CDG-1l)"	118	118	1	0.00847457627118644	118	118	21	0.177966101694915	0.298245614035088	17	24	3	0	0.865381420041784	1
"946"	"Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2"	118	118	1	0.00847457627118644	118	118	21	0.177966101694915	0.298245614035088	17	24	3	0	0.865381420041784	1
"947"	"Defective MAN1B1 causes MRT15"	118	118	1	0.00847457627118644	118	118	21	0.177966101694915	0.298245614035088	17	24	3	0	0.865381420041784	1
"948"	"Defective MGAT2 causes MGAT2-CDG (CDG-2a)"	118	118	1	0.00847457627118644	118	118	21	0.177966101694915	0.298245614035088	17	24	3	0	0.865381420041784	1
"949"	"Defective MOGS causes MOGS-CDG (CDG-2b)"	118	118	1	0.00847457627118644	118	118	21	0.177966101694915	0.298245614035088	17	24	3	0	0.865381420041784	1
"950"	"Defective MPDU1 causes MPDU1-CDG (CDG-1f)"	118	118	1	0.00847457627118644	118	118	21	0.177966101694915	0.298245614035088	17	24	3	0	0.865381420041784	1
"951"	"Defective RFT1 causes RFT1-CDG (CDG-1n)"	118	118	1	0.00847457627118644	118	118	21	0.177966101694915	0.298245614035088	17	24	3	0	0.865381420041784	1
"952"	"Diseases associated with N-glycosylation of proteins"	118	118	1	0.00847457627118644	118	118	21	0.177966101694915	0.298245614035088	17	24	3	0	0.865381420041784	1
"459"	"Prefoldin mediated transfer of substrate  to CCT/TriC"	26	26	4	0.153846153846154	26	26	3	0.115384615384615	0.0526315789473684	3	3	1	0	0.866321233740982	1
"240"	"G1/S Transition"	109	109	30	0.275229357798165	109	109	19	0.174311926605505	0.315789473684211	18	23	4	0	0.874336000792321	1
"180"	"Hedgehog ligand biogenesis"	64	64	20	0.3125	64	64	10	0.15625	0.12280701754386	7	10	1	0	0.878653695604146	1
"181"	"Processing-defective Hh variants abrogate ligand secretion"	64	64	20	0.3125	64	64	10	0.15625	0.12280701754386	7	10	1	0	0.878653695604146	1
"198"	"ER-Phagosome pathway"	64	64	19	0.296875	64	64	10	0.15625	0.210526315789474	12	12	3	0	0.878653695604146	1
"681"	"Class I MHC mediated antigen processing & presentation"	255	255	21	0.0823529411764706	255	255	49	0.192156862745098	0.649122807017544	37	74	7	0	0.879549703168267	1
"531"	"Adaptive Immune System"	654	654	82	0.125382262996942	654	654	134	0.204892966360856	0.87719298245614	50	195	15	0	0.882031637822796	1
"124"	"degradation of AXIN"	54	54	20	0.37037037037037	54	54	8	0.148148148148148	0.12280701754386	7	8	1	0	0.883837920460626	1
"142"	"AUF1 (hnRNP D0) destabilizes mRNA"	54	54	19	0.351851851851852	54	54	8	0.148148148148148	0.12280701754386	7	9	2	0	0.883837920460626	1
"143"	"SCF-beta-TrCP mediated degradation of Emi1"	54	54	19	0.351851851851852	54	54	8	0.148148148148148	0.140350877192982	8	8	1	0	0.883837920460626	1
"465"	"Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding"	27	27	4	0.148148148148148	27	27	3	0.111111111111111	0.0526315789473684	3	3	1	0	0.885474315450115	1
"273"	"Regulation of DNA replication"	75	75	20	0.266666666666667	75	75	12	0.16	0.245614035087719	14	15	4	0	0.887267299597721	1
"79"	"Regulation of activated PAK-2p34 by proteasome mediated degradation"	49	49	20	0.408163265306122	49	49	7	0.142857142857143	0.105263157894737	6	7	1	0	0.887594464293215	1
"663"	"deactivation of the beta-catenin transactivating complex"	33	33	3	0.0909090909090909	33	33	4	0.121212121212121	0.192982456140351	11	11	8	0	0.891728950177717	1
"326"	"PCP/CE pathway"	91	91	20	0.21978021978022	91	91	15	0.164835164835165	0.228070175438596	13	17	3	0	0.894690305146426	1
"108"	"Regulation of ornithine decarboxylase (ODC)"	50	50	19	0.38	50	50	7	0.14	0.12280701754386	7	7	1	0	0.900445278830622	1
"147"	"Activation of NF-kappaB in B cells"	66	66	23	0.348484848484849	66	66	10	0.151515151515152	0.140350877192982	8	11	2	0	0.901921799524606	1
"155"	"Cyclin A:Cdk2-associated events at S phase entry"	66	66	22	0.333333333333333	66	66	10	0.151515151515152	0.210526315789474	12	14	4	0	0.901921799524606	1
"789"	"Chromosome Maintenance"	87	87	4	0.0459770114942529	87	87	14	0.160919540229885	0.210526315789474	12	15	2	0	0.905022012045458	1
"649"	"Antigen processing: Ubiquitination & Proteasome degradation"	211	211	20	0.0947867298578199	211	211	39	0.184834123222749	0.56140350877193	32	58	7	0	0.905653131346405	1
"123"	"Autodegradation of the E3 ubiquitin ligase COP1"	51	51	19	0.372549019607843	51	51	7	0.137254901960784	0.12280701754386	7	7	1	0	0.912033297019518	1
"223"	"Assembly of the pre-replicative complex"	67	67	19	0.283582089552239	67	67	10	0.149253731343284	0.157894736842105	9	10	1	0	0.912090300891883	1
"911"	"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein"	67	67	1	0.0149253731343284	67	67	10	0.149253731343284	0.157894736842105	9	10	1	0	0.912090300891883	1
"879"	"Glycerophospholipid biosynthesis"	88	88	2	0.0227272727272727	88	88	14	0.159090909090909	0.245614035087719	14	17	2	0	0.913814451011641	1
"550"	"HIV Infection"	227	227	28	0.123348017621145	227	227	42	0.185022026431718	0.43859649122807	25	51	3	0	0.913903300378065	1
"306"	"Metabolism of nucleotides"	78	78	18	0.230769230769231	78	78	12	0.153846153846154	0.175438596491228	10	12	1	0	0.916897561722972	1
"575"	"Regulation of HSF1-mediated heat shock response"	35	35	4	0.114285714285714	35	35	4	0.114285714285714	0.12280701754386	7	7	3	0	0.919406683254122	1
"568"	"Phosphorylation of the APC/C"	17	17	2	0.117647058823529	17	17	1	0.0588235294117647	0.0175438596491228	1	1	1	0	0.921090349694135	1
"128"	"Stabilization of p53"	52	52	19	0.365384615384615	52	52	7	0.134615384615385	0.12280701754386	7	7	1	0	0.922448962996463	1
"187"	"Asymmetric localization of PCP proteins"	63	63	19	0.301587301587302	63	63	9	0.142857142857143	0.157894736842105	9	9	1	0	0.924252777291005	1
"327"	"DNA Replication"	105	105	23	0.219047619047619	105	105	17	0.161904761904762	0.298245614035088	17	20	4	0	0.925984419951913	1
"210"	"Cdc20:Phospho-APC/C mediated degradation of Cyclin A"	69	69	20	0.289855072463768	69	69	10	0.144927536231884	0.140350877192982	8	10	1	0	0.929782726125137	1
"419"	"Amine ligand-binding receptors"	42	42	7	0.166666666666667	42	42	5	0.119047619047619	0.0701754385964912	4	5	1	0	0.933399814747258	1
"237"	"Synthesis and interconversion of nucleotide di- and triphosphates"	18	18	5	0.277777777777778	18	18	1	0.0555555555555556	0.0175438596491228	1	1	1	0	0.935811665100577	1
"675"	"Chaperonin-mediated protein folding"	48	48	4	0.0833333333333333	48	48	6	0.125	0.140350877192982	8	9	3	0	0.936634750757079	1
"192"	"APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint"	70	70	21	0.3	70	70	10	0.142857142857143	0.140350877192982	8	10	1	0	0.937421690335515	1
"144"	"Vif-mediated degradation of APOBEC3G"	54	54	19	0.351851851851852	54	54	7	0.12962962962963	0.12280701754386	7	7	1	0	0.940120067229828	1
"756"	"RNA Polymerase I Promoter Clearance"	76	76	4	0.0526315789473684	76	76	11	0.144736842105263	0.192982456140351	11	12	2	0	0.941856413913905	1
"78"	"Cross-presentation of soluble exogenous antigens (endosomes)"	49	49	20	0.408163265306122	49	49	6	0.122448979591837	0.105263157894737	6	6	1	0	0.94480813183439	1
"447"	"RNF mutants show enhanced WNT signaling and proliferation"	190	190	30	0.157894736842105	190	190	33	0.173684210526316	0.578947368421053	33	54	8	0	0.94809576471113	1
"449"	"TCF dependent signaling in response to WNT"	190	190	30	0.157894736842105	190	190	33	0.173684210526316	0.578947368421053	33	54	8	0	0.94809576471113	1
"450"	"XAV939 inhibits tankyrase, stabilizing AXIN"	190	190	30	0.157894736842105	190	190	33	0.173684210526316	0.578947368421053	33	54	8	0	0.94809576471113	1
"451"	"misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling"	190	190	30	0.157894736842105	190	190	33	0.173684210526316	0.578947368421053	33	54	8	0	0.94809576471113	1
"219"	"Regulation of APC/C activators between G1/S and early anaphase"	77	77	22	0.285714285714286	77	77	11	0.142857142857143	0.157894736842105	9	11	1	0	0.948136447537591	1
"759"	"Negative epigenetic regulation of rRNA expression"	77	77	4	0.051948051948052	77	77	11	0.142857142857143	0.192982456140351	11	13	2	0	0.948136447537591	1
"673"	"Organelle biogenesis and maintenance"	323	323	27	0.0835913312693498	323	323	60	0.185758513931889	0.56140350877193	32	77	4	0	0.949555343632783	1
"207"	"APC/C:Cdc20 mediated degradation of mitotic proteins"	72	72	21	0.291666666666667	72	72	10	0.138888888888889	0.140350877192982	8	10	1	0	0.950566063633084	1
"190"	"APC/C-mediated degradation of cell cycle proteins"	83	83	25	0.301204819277108	83	83	12	0.144578313253012	0.175438596491228	10	13	2	0	0.951721083019441	1
"191"	"Regulation of mitotic cell cycle"	83	83	25	0.301204819277108	83	83	12	0.144578313253012	0.175438596491228	10	13	2	0	0.951721083019441	1
"74"	"Ubiquitin-dependent degradation of Cyclin D"	50	50	21	0.42	50	50	6	0.12	0.105263157894737	6	6	1	0	0.952029991625701	1
"75"	"Ubiquitin-dependent degradation of Cyclin D1"	50	50	21	0.42	50	50	6	0.12	0.105263157894737	6	6	1	0	0.952029991625701	1
"85"	"CDK-mediated phosphorylation and removal of Cdc6"	50	50	20	0.4	50	50	6	0.12	0.105263157894737	6	6	1	0	0.952029991625701	1
"762"	"RNA Polymerase I Transcription"	78	78	4	0.0512820512820513	78	78	11	0.141025641025641	0.192982456140351	11	12	2	0	0.953816244958431	1
"188"	"Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins"	73	73	22	0.301369863013699	73	73	10	0.136986301369863	0.140350877192982	8	10	1	0	0.956179132339039	1
"381"	"Xenobiotics"	20	20	4	0.2	20	20	1	0.05	0.0175438596491228	1	1	1	0	0.957800240064937	1
"145"	"p53-Dependent G1 DNA Damage Response"	57	57	20	0.350877192982456	57	57	7	0.12280701754386	0.12280701754386	7	7	1	0	0.95999459124755	1
"146"	"p53-Dependent G1/S DNA damage checkpoint"	57	57	20	0.350877192982456	57	57	7	0.12280701754386	0.12280701754386	7	7	1	0	0.95999459124755	1
"753"	"NoRC negatively regulates rRNA expression"	74	74	4	0.0540540540540541	74	74	10	0.135135135135135	0.192982456140351	11	12	2	0	0.961221090984808	1
"700"	"Biological oxidations"	174	174	13	0.0747126436781609	174	174	29	0.166666666666667	0.333333333333333	19	33	2	0	0.962788098023745	1
"176"	"APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1"	69	69	22	0.318840579710145	69	69	9	0.130434782608696	0.140350877192982	8	10	2	0	0.963762636336245	1
"80"	"Ubiquitin Mediated Degradation of Phosphorylated Cdc25A"	52	52	21	0.403846153846154	52	52	6	0.115384615384615	0.105263157894737	6	6	1	0	0.963984412663305	1
"81"	"p53-Independent DNA Damage Response"	52	52	21	0.403846153846154	52	52	6	0.115384615384615	0.105263157894737	6	6	1	0	0.963984412663305	1
"82"	"p53-Independent G1/S DNA damage checkpoint"	52	52	21	0.403846153846154	52	52	6	0.115384615384615	0.105263157894737	6	6	1	0	0.963984412663305	1
"106"	"Vpu mediated degradation of CD4"	52	52	20	0.384615384615385	52	52	6	0.115384615384615	0.105263157894737	6	6	1	0	0.963984412663305	1
"148"	"Hh ligand biogenesis disease"	58	58	20	0.344827586206897	58	58	7	0.120689655172414	0.105263157894737	6	7	1	0	0.965162605509994	1
"172"	"CDT1 association with the CDC6:ORC:origin complex"	58	58	19	0.327586206896552	58	58	7	0.120689655172414	0.12280701754386	7	7	1	0	0.965162605509994	1
"342"	"Cell Cycle Checkpoints"	118	118	25	0.211864406779661	118	118	18	0.152542372881356	0.245614035087719	14	18	1	0	0.965468169407226	1
"197"	"APC/C:Cdc20 mediated degradation of Securin"	64	64	19	0.296875	64	64	8	0.125	0.12280701754386	7	8	1	0	0.966588598904454	1
"250"	"AMER1 mutants destabilize the destruction complex"	82	82	22	0.268292682926829	82	82	11	0.134146341463415	0.175438596491228	10	11	1	0	0.971427222396439	1
"251"	"APC truncation mutants are not K63 polyubiquitinated"	82	82	22	0.268292682926829	82	82	11	0.134146341463415	0.175438596491228	10	11	1	0	0.971427222396439	1
"252"	"APC truncation mutants have impaired AXIN binding"	82	82	22	0.268292682926829	82	82	11	0.134146341463415	0.175438596491228	10	11	1	0	0.971427222396439	1
"253"	"AXIN missense mutants destabilize the destruction complex"	82	82	22	0.268292682926829	82	82	11	0.134146341463415	0.175438596491228	10	11	1	0	0.971427222396439	1
"254"	"AXIN mutants destabilize the destruction complex, activating WNT signaling"	82	82	22	0.268292682926829	82	82	11	0.134146341463415	0.175438596491228	10	11	1	0	0.971427222396439	1
"255"	"DNA Replication Pre-Initiation"	82	82	22	0.268292682926829	82	82	11	0.134146341463415	0.157894736842105	9	11	1	0	0.971427222396439	1
"256"	"Degradation of beta-catenin by the destruction complex"	82	82	22	0.268292682926829	82	82	11	0.134146341463415	0.175438596491228	10	11	1	0	0.971427222396439	1
"257"	"M/G1 Transition"	82	82	22	0.268292682926829	82	82	11	0.134146341463415	0.157894736842105	9	11	1	0	0.971427222396439	1
"258"	"S33 mutants of beta-catenin aren't phosphorylated"	82	82	22	0.268292682926829	82	82	11	0.134146341463415	0.175438596491228	10	11	1	0	0.971427222396439	1
"259"	"S37 mutants of beta-catenin aren't phosphorylated"	82	82	22	0.268292682926829	82	82	11	0.134146341463415	0.175438596491228	10	11	1	0	0.971427222396439	1
"260"	"S45 mutants of beta-catenin aren't phosphorylated"	82	82	22	0.268292682926829	82	82	11	0.134146341463415	0.175438596491228	10	11	1	0	0.971427222396439	1
"261"	"T41 mutants of beta-catenin aren't phosphorylated"	82	82	22	0.268292682926829	82	82	11	0.134146341463415	0.175438596491228	10	11	1	0	0.971427222396439	1
"262"	"TCF7L2 mutants don't bind CTBP"	82	82	22	0.268292682926829	82	82	11	0.134146341463415	0.175438596491228	10	11	1	0	0.971427222396439	1
"263"	"deletions in the AMER1 gene destabilize the destruction complex"	82	82	22	0.268292682926829	82	82	11	0.134146341463415	0.175438596491228	10	11	1	0	0.971427222396439	1
"264"	"deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling"	82	82	22	0.268292682926829	82	82	11	0.134146341463415	0.175438596491228	10	11	1	0	0.971427222396439	1
"265"	"misspliced GSK3beta mutants stabilize beta-catenin"	82	82	22	0.268292682926829	82	82	11	0.134146341463415	0.175438596491228	10	11	1	0	0.971427222396439	1
"266"	"phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex"	82	82	22	0.268292682926829	82	82	11	0.134146341463415	0.175438596491228	10	11	1	0	0.971427222396439	1
"267"	"truncated APC mutants destabilize the destruction complex"	82	82	22	0.268292682926829	82	82	11	0.134146341463415	0.175438596491228	10	11	1	0	0.971427222396439	1
"268"	"truncations of AMER1 destabilize the destruction complex"	82	82	22	0.268292682926829	82	82	11	0.134146341463415	0.175438596491228	10	11	1	0	0.971427222396439	1
"829"	"RNA Polymerase I Promoter Escape"	29	29	1	0.0344827586206897	29	29	2	0.0689655172413793	0.0350877192982456	2	2	1	0	0.972638474375427	1
"703"	"Protein folding"	54	54	4	0.0740740740740741	54	54	6	0.111111111111111	0.140350877192982	8	9	3	0	0.973168890934585	1
"126"	"G1/S DNA Damage Checkpoints"	60	60	22	0.366666666666667	60	60	7	0.116666666666667	0.12280701754386	7	7	1	0	0.973726806334315	1
"861"	"Beta defensins"	36	36	1	0.0277777777777778	36	36	3	0.0833333333333333	0.0526315789473684	3	3	1	0	0.974777464625926	1
"880"	"Defective AHCY causes Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency (HMAHCHD)"	89	89	2	0.0224719101123595	89	89	12	0.134831460674157	0.157894736842105	9	13	2	0	0.976129305760122	1
"881"	"Defective GCLC causes Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD)"	89	89	2	0.0224719101123595	89	89	12	0.134831460674157	0.157894736842105	9	13	2	0	0.976129305760122	1
"882"	"Defective GGT1 causes Glutathionuria (GLUTH)"	89	89	2	0.0224719101123595	89	89	12	0.134831460674157	0.157894736842105	9	13	2	0	0.976129305760122	1
"883"	"Defective GSS causes Glutathione synthetase deficiency (GSS deficiency)"	89	89	2	0.0224719101123595	89	89	12	0.134831460674157	0.157894736842105	9	13	2	0	0.976129305760122	1
"884"	"Defective MAT1A causes Methionine adenosyltransferase deficiency (MATD)"	89	89	2	0.0224719101123595	89	89	12	0.134831460674157	0.157894736842105	9	13	2	0	0.976129305760122	1
"885"	"Defective OPLAH causes 5-oxoprolinase deficiency (OPLAHD)"	89	89	2	0.0224719101123595	89	89	12	0.134831460674157	0.157894736842105	9	13	2	0	0.976129305760122	1
"886"	"Defective SLC35D1 causes Schneckenbecken dysplasia (SCHBCKD)"	89	89	2	0.0224719101123595	89	89	12	0.134831460674157	0.157894736842105	9	13	2	0	0.976129305760122	1
"887"	"Defective TPMT causes Thiopurine S-methyltransferase deficiency (TPMT deficiency)"	89	89	2	0.0224719101123595	89	89	12	0.134831460674157	0.157894736842105	9	13	2	0	0.976129305760122	1
"888"	"Defective UGT1A1 causes hyperbilirubinemia"	89	89	2	0.0224719101123595	89	89	12	0.134831460674157	0.157894736842105	9	13	2	0	0.976129305760122	1
"889"	"Defective UGT1A4 causes hyperbilirubinemia"	89	89	2	0.0224719101123595	89	89	12	0.134831460674157	0.157894736842105	9	13	2	0	0.976129305760122	1
"890"	"Phase II conjugation"	89	89	2	0.0224719101123595	89	89	12	0.134831460674157	0.157894736842105	9	13	2	0	0.976129305760122	1
"704"	"Chemokine receptors bind chemokines"	55	55	4	0.0727272727272727	55	55	6	0.109090909090909	0.12280701754386	7	7	2	0	0.976905257386491	1
"698"	"Metabolism"	1565	1565	120	0.0766773162939297	1565	1565	321	0.205111821086262	0.947368421052632	54	398	15	0	0.977058254859322	1
"786"	"Peptide ligand-binding receptors"	190	190	9	0.0473684210526316	190	190	31	0.163157894736842	0.456140350877193	26	36	2	0	0.977367305764145	1
"249"	"Generation of second messenger molecules"	37	37	10	0.27027027027027	37	37	3	0.0810810810810811	0.0526315789473684	3	3	1	0	0.978915993646665	1
"485"	"Signaling by WNT in cancer"	212	212	30	0.141509433962264	212	212	35	0.165094339622642	0.578947368421053	33	56	8	0	0.980139247396469	1
"906"	"RNA Polymerase I Chain Elongation"	56	56	1	0.0178571428571429	56	56	6	0.107142857142857	0.105263157894737	6	6	1	0	0.980156400657029	1
"324"	"FCGR activation"	50	50	11	0.22	50	50	5	0.1	0.0701754385964912	4	5	1	0	0.980339111779701	1
"848"	"RNA Polymerase I Transcription Termination"	31	31	1	0.032258064516129	31	31	2	0.0645161290322581	0.0350877192982456	2	2	1	0	0.981461625739989	1
"506"	"FCERI mediated NF-kB activation"	57	57	8	0.140350877192982	57	57	6	0.105263157894737	0.12280701754386	7	8	2	0	0.982979053974356	1
"298"	"Phosphorylation of CD3 and TCR zeta chains"	25	25	6	0.24	25	25	1	0.04	0.0175438596491228	1	1	1	0	0.98565098387712	1
"863"	"Binding and Uptake of Ligands by Scavenger Receptors"	76	76	2	0.0263157894736842	76	76	9	0.118421052631579	0.210526315789474	12	14	3	0	0.985814648922773	1
"177"	"Autodegradation of Cdh1 by Cdh1:APC/C"	60	60	19	0.316666666666667	60	60	6	0.1	0.087719298245614	5	6	1	0	0.98936284194475	1
"587"	"Metabolism of amino acids and derivatives"	188	188	21	0.111702127659574	188	188	29	0.154255319148936	0.350877192982456	20	31	2	0	0.989572120342497	1
"913"	"Influenza Life Cycle"	143	143	2	0.013986013986014	143	143	20	0.13986013986014	0.210526315789474	12	22	2	0	0.992588202144364	1
"711"	"Complement cascade"	75	75	5	0.0666666666666667	75	75	8	0.106666666666667	0.140350877192982	8	11	3	0	0.993075924990552	1
"827"	"Class B/2 (Secretin family receptors)"	87	87	3	0.0344827586206897	87	87	10	0.114942528735632	0.175438596491228	10	12	2	0	0.993117100423148	1
"777"	"GPCR downstream signaling"	966	966	46	0.0476190476190476	966	966	186	0.192546583850932	0.929824561403509	53	236	15	0	0.993888267653495	1
"903"	"Metabolism of proteins"	694	694	13	0.0187319884726225	694	694	129	0.185878962536023	0.736842105263158	42	172	9	0	0.994212167972814	1
"912"	"Influenza Viral RNA Transcription and Replication"	135	135	2	0.0148148148148148	135	135	18	0.133333333333333	0.192982456140351	11	19	2	0	0.994827592962743	1
"895"	"Influenza Infection"	148	148	3	0.0202702702702703	148	148	20	0.135135135135135	0.210526315789474	12	22	2	0	0.995853759630762	1
"800"	"Defensins"	46	46	2	0.0434782608695652	46	46	3	0.0652173913043478	0.0526315789473684	3	3	1	0	0.996098252127241	1
"734"	"Signaling by GPCR"	1078	1078	66	0.0612244897959184	1078	1078	207	0.192022263450835	0.929824561403509	53	263	15	0	0.996736503406189	1
"891"	"Scavenging of heme from plasma"	47	47	1	0.0212765957446809	47	47	3	0.0638297872340425	0.0701754385964912	4	5	2	0	0.996787928396942	1
"709"	"Class A/1 (Rhodopsin-like receptors)"	314	314	22	0.0700636942675159	314	314	50	0.159235668789809	0.578947368421053	33	55	2	0	0.99770926212838	1
"752"	"Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"	111	111	6	0.0540540540540541	111	111	12	0.108108108108108	0.228070175438596	13	14	3	0	0.998795292703898	1
"920"	"Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)"	89	89	1	0.0112359550561798	89	89	7	0.0786516853932584	0.087719298245614	5	8	2	0	0.999766496377453	1
"957"	"The citric acid (TCA) cycle and respiratory electron transport"	147	147	1	0.00680272108843537	147	147	16	0.108843537414966	0.245614035087719	14	18	2	0	0.999783689912531	1
"585"	"Classical antibody-mediated complement activation"	44	44	5	0.113636363636364	44	44	1	0.0227272727272727	0.0175438596491228	1	1	1	0	0.999811170565336	1
"745"	"Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)"	441	441	25	0.0566893424036281	441	441	69	0.156462585034014	0.701754385964912	40	78	2	0	0.999823794288722	1
"746"	"GPCR ligand binding"	441	441	25	0.0566893424036281	441	441	69	0.156462585034014	0.701754385964912	40	78	2	0	0.999823794288722	1
"680"	"Disease"	1954	1954	162	0.082906857727738	1954	1954	381	0.194984646878199	0.982456140350877	56	489	15	0	0.99982874461683	1
"921"	"Mitochondrial translation"	92	92	1	0.0108695652173913	92	92	7	0.0760869565217391	0.087719298245614	5	7	1	0	0.999863940095541	1
"929"	"Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)"	106	106	1	0.00943396226415094	106	106	9	0.0849056603773585	0.140350877192982	8	12	2	0	0.999873506770583	1
"930"	"Nonsense-Mediated Decay (NMD)"	106	106	1	0.00943396226415094	106	106	9	0.0849056603773585	0.140350877192982	8	12	2	0	0.999873506770583	1
"917"	"Mitochondrial translation initiation"	86	86	1	0.0116279069767442	86	86	6	0.0697674418604651	0.0701754385964912	4	6	1	0	0.999887427153442	1
"918"	"Mitochondrial translation termination"	86	86	1	0.0116279069767442	86	86	6	0.0697674418604651	0.087719298245614	5	6	1	0	0.999887427153442	1
"667"	"Initial triggering of complement"	57	57	5	0.087719298245614	57	57	2	0.0350877192982456	0.0350877192982456	2	2	1	0	0.999924452650862	1
"631"	"Creation of C4 and C2 activators"	50	50	5	0.1	50	50	1	0.02	0.0175438596491228	1	1	1	0	0.999954030180852	1
"914"	"Eukaryotic Translation Termination"	84	84	1	0.0119047619047619	84	84	5	0.0595238095238095	0.0701754385964912	4	5	1	0	0.999959711485275	1
"915"	"Peptide chain elongation"	84	84	1	0.0119047619047619	84	84	5	0.0595238095238095	0.087719298245614	5	5	1	0	0.999959711485275	1
"916"	"Mitochondrial translation elongation"	86	86	1	0.0116279069767442	86	86	5	0.0581395348837209	0.0701754385964912	4	5	1	0	0.999972928618025	1
"919"	"Eukaryotic Translation Elongation"	89	89	1	0.0112359550561798	89	89	5	0.0561797752808989	0.087719298245614	5	5	1	0	0.999985163798811	1
"926"	"3' -UTR-mediated translational regulation"	104	104	1	0.00961538461538462	104	104	7	0.0673076923076923	0.105263157894737	6	8	2	0	0.999985378163991	1
"927"	"L13a-mediated translational silencing of Ceruloplasmin expression"	104	104	1	0.00961538461538462	104	104	7	0.0673076923076923	0.105263157894737	6	8	2	0	0.999985378163991	1
"733"	"Metabolic disorders of biological oxidation enzymes"	614	614	38	0.0618892508143322	614	614	97	0.157980456026059	0.789473684210526	45	110	2	0	0.999985898754323	1
"932"	"Cap-dependent Translation Initiation"	112	112	1	0.00892857142857143	112	112	8	0.0714285714285714	0.140350877192982	8	10	2	0	0.999987444335246	1
"933"	"Eukaryotic Translation Initiation"	112	112	1	0.00892857142857143	112	112	8	0.0714285714285714	0.140350877192982	8	10	2	0	0.999987444335246	1
"928"	"GTP hydrolysis and joining of the 60S ribosomal subunit"	105	105	1	0.00952380952380952	105	105	7	0.0666666666666667	0.105263157894737	6	8	2	0	0.999987914026917	1
"922"	"Viral mRNA Translation"	92	92	1	0.0108695652173913	92	92	5	0.0543478260869565	0.087719298245614	5	5	1	0	0.99999191544692	1
"923"	"Formation of a pool of free 40S subunits"	94	94	1	0.0106382978723404	94	94	5	0.0531914893617021	0.0701754385964912	4	5	1	0	0.999994622601799	1
"958"	"Translation"	148	148	1	0.00675675675675676	148	148	12	0.0810810810810811	0.175438596491228	10	14	2	0	0.999997124206864	1
"931"	"SRP-dependent cotranslational protein targeting to membrane"	109	109	1	0.00917431192660551	109	109	6	0.055045871559633	0.087719298245614	5	6	1	0	0.999998752512887	1
"960"	"Estrogen biosynthesis"	2	2	1	0.5	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"961"	"Inhibition of HSL"	2	2	1	0.5	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"962"	"Signaling by FGFR1 amplification mutants"	1	1	1	1	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"963"	"Signaling by FGFR2 amplification mutants"	1	1	1	1	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"964"	"SHC activation"	4	4	1	0.25	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"965"	"Mitotic Metaphase/Anaphase Transition"	2	2	1	0.5	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"966"	"RAF activation"	5	5	1	0.2	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"967"	"GABA A (rho) receptor activation"	3	3	1	0.333333333333333	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"968"	"PDE3B signalling"	2	2	1	0.5	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"969"	"SMAC binds to IAPs"	5	5	1	0.2	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"970"	"SMAC-mediated apoptotic response"	5	5	1	0.2	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"971"	"Resolution of D-loop structures"	2	2	1	0.5	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"972"	"Activation of BIM and translocation to mitochondria"	3	3	2	0.666666666666667	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"973"	"Activation of TRKA receptors"	6	6	2	0.333333333333333	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"974"	"Regulation of gap junction activity"	3	3	1	0.333333333333333	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"975"	"Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex"	5	5	3	0.6	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"976"	"Dopamine clearance from the synaptic cleft"	3	3	1	0.333333333333333	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"977"	"FGFR1c and Klotho ligand binding and activation"	3	3	1	0.333333333333333	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"978"	"Host Interactions with Influenza Factors"	8	8	1	0.125	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"979"	"AMPK inhibits chREBP transcriptional activation activity"	5	5	2	0.4	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"980"	"Carnitine synthesis"	4	4	1	0.25	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"981"	"Metabolism of folate and pterines"	9	9	5	0.555555555555556	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"982"	"Adenosine P1 receptors"	4	4	2	0.5	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"983"	"Cyclin B2 mediated events"	5	5	1	0.2	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"984"	"c-src mediated regulation of Cx43 function and closure of gap junctions"	3	3	1	0.333333333333333	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"985"	"Enzymatic degradation of Dopamine by monoamine oxidase"	2	2	1	0.5	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"986"	"Mineralocorticoid biosynthesis"	6	6	1	0.166666666666667	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"987"	"SMAC-mediated dissociation of IAP:caspase complexes"	5	5	1	0.2	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"988"	"Post-chaperonin tubulin folding pathway"	18	18	4	0.222222222222222	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"989"	"STAT6-mediated induction of chemokines"	3	3	1	0.333333333333333	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"990"	"NS1 Mediated Effects on Host Pathways"	4	4	1	0.25	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"991"	"Clearance of Nuclear Envelope Membranes from Chromatin"	7	7	1	0.142857142857143	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"992"	"Alpha-defensins"	10	10	1	0.1	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"993"	"NGF-independant TRKA activation"	5	5	2	0.4	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"994"	"Activation of PKB"	4	4	2	0.5	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"995"	"Translocation of ZAP-70 to Immunological synapse"	23	23	6	0.260869565217391	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"996"	"Assembly of the RAD51-ssDNA nucleoprotein complex"	5	5	1	0.2	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"997"	"TNF signaling"	3	3	1	0.333333333333333	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"998"	"Interleukin-1 processing"	7	7	1	0.142857142857143	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"999"	"Enzymatic degradation of dopamine by COMT"	2	2	1	0.5	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"1000"	"PD-1 signaling"	28	28	7	0.25	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"1001"	"Heme degradation"	6	6	1	0.166666666666667	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"1002"	"Inhibition of PKR"	2	2	1	0.5	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"1003"	"TRKA activation by NGF"	2	2	1	0.5	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"1004"	"Binding and entry of HIV virion"	12	12	2	0.166666666666667	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"1005"	"Activation of BMF and translocation to mitochondria"	3	3	1	0.333333333333333	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"1006"	"Resolution of D-loop structures through Holliday junction intermediates"	2	2	1	0.5	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"1007"	"Pyrimidine biosynthesis"	6	6	1	0.166666666666667	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"1008"	"Telomere Extension By Telomerase"	6	6	1	0.166666666666667	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
